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ABSTRACT
Purpose: To investigate: 1) if a self-paced (SP) graded exercise testing protocol elicits
similar and reliable maximal oxygen uptake (VO2max) responses compared to a ramp
(RAMP) treadmill protocol; 2) the impact of SP on cardiac output (Q), stroke volume
(SV), and arteriovenous oxygen difference (a-vO2diff); and 3) the metabolic response
during SP through blood lactate (BLa-) accumulation and ventilatory threshold (VT)
attainment. Methods: Sixteen recreationally trained men (23.7±3.0 yrs) completed two
separate treadmill graded exercise testing protocols. SP consisted of five 2-min stages (10
min total) of increasing speed based on the Borg RPE6-20 scale. RAMP consisted of
increases in speed by 0.16 km/hr every 15 s until volitional exhaustion. All tests were
performed at 3% incline. VO2 was measured via indirect calorimetry, hemodynamic
function was measured via thoracic impedance, and BLa- was measured via portable
lactate analyzer. Differences between SP and RAMP protocols were analyzed as group
means by using paired samples t-tests (R Core Team (2017)). Results: Maximal values
for SP and RAMP were similar (p>0.05) for VO2max (47.1±3.4 vs. 47.4±3.4 mL•kg-1•min1

), heart rate (198±5 vs. 200±6 beat•min-1), ventilation (158.8±20.7 vs. 159.3±19.0 L•min-

1

), Q (26.9±5.5 vs. 27.9±4.2 L•min-1), SV (145.9±29.2 vs. 149.8±25.3 mL•beat-1), a-

vO2diff (18.5±3.1 vs. 19.7±3.1 mL•dL-1), VT (78.2 ± 7.2 vs. 79.0 ± 7.6% VO2max), and
peak BLa- (11.7±2.3 vs. 11.5±2.4 mM•L-1), respectively. Conclusions: SP elicits similar
physiological responses in comparison to RAMP. These results support SP as a feasible
GXT protocol. Electing to employ SP may benefit clinicians and researchers from a timemanagement perspective.
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CHAPTER 1
Introduction
Since its inception in the pioneering work of Hill, Long, and Lupton (1923), the
concept of maximal oxygen consumption (VO2max) has been the most widely examined
variable in the field of exercise physiology (Noakes, 2008). Typically, VO2max is
obtained by administering a graded exercise test (GXT) to examine the dynamic
relationship between exercise workload and the integrated cardiovascular, pulmonary,
musculoskeletal, and neurophysiological systems (Albouaini et al., 2007). Altogether, the
relationship depicts the upper limits of systems to collectively deliver oxygenated blood
to working skeletal muscle and the ability of skeletal muscle to utilize oxygen for work.
Therefore, results obtained from a GXT are the basis for a large spectrum of applications,
ranging from clinical exercise tolerance and appropriateness for surgery to research on
the efficacy of aerobic training programs in athletic performance.
Historically, GXTs were administered in a discontinuous fashion (Taylor et al.,
1955). That is, responses to exercise were evaluated by completing a series of singlestage exercise tests of incremental intensities on separate days. Taylor et al. (1955) were
the first to demonstrate the reliability of such testing, noting that modality, fitness status,
test duration, and intensity increment were all important considerations when attempting
to accurately capture VO2max. In an effort to highlight inconsistencies between continuous
GXT protocols, Pollock et al. (1976) evaluated the ability of four popular treadmill
protocols (Balke, Bruce, Ellestad, and Modified Astrand) to assess maximal
cardiorespiratory responses. Although no differences were found between tests for
VO2max, the unique step-wise challenge applied by each protocol demonstrated the

2

variability in ventilatory and metabolic responses across protocols. Investigations by
Whipp et al. (1981) and Davis et al. (1982) popularized the use of ramp protocols on
electronically braked cycle ergometers. Given the workload was delivered in a linear
rather than step fashion, observations examined the slope in VO2-workload relationships
and the optimal progression of work rates (Buchfuhrer et al., 1983; Zhang et al., 1991).
Since then, there has been a trend in research toward establishing an optimal and
standardized GXT protocol suitable for all fitness levels and testing goals.
Despite the widespread importance of measuring VO2max, the methodology in
which graded exercise tests are applied and even the conceptualization of VO2max itself
has created recent controversy (Mauger and Sculthorpe, 2012; Mauger et al., 2013;
Chidnok et al., 2013; Levine, 2008). Hagerman (1984) originally reported confounding
evidence, highlighting the limitations of the continuous GXT by demonstrating the ability
of individuals to reach a greater VO2max during simulated competition compared to
laboratory-based methods. These findings suggested that an individual and his/her ability
to self-modulate muscular power output on a momentary basis may serve as the ultimate
variable in maximizing physiological responses during exercise. Therefore, strategies in
self-pacing similar to those exhibited during athletic competition may be the limiting
factor in performance during a GXT.
Noakes (2008) introduced a three-fold model concerning the appropriateness and
utility of continuous GXTs to elicit VO2max. First, the test is administered in an “open
loop” rather than “closed loop” fashion, meaning that the participant is unaware of when
the test will end. Second, the nature of the exercise itself is not representative of natural
exercise because it is delivered in predetermined and fixed increments. Lastly, the
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subjectivity of the test may limit reliability because the test only concludes upon the
participant reaching volitional exhaustion.
These criticisms, coupled with the high inter-subject variability of the primary
(VO2 plateau) and secondary (rating of perceived exertion or ‘RPE’, blood lactate (BLa-),
respiratory exchange ratio, heart rate) criteria applied to verify the attainment of a ‘true’
VO2max have led to the recent application of self-paced GXT protocols coupled with
supramaximal verification bouts. Mauger and Sculthorpe (2012) developed a novel
“closed loop” GXT design that does not rely on predetermined and fixed intensity
increments by a test administrator, but rather allows the participant to self-select intensity
throughout the bout via “RPE clamping.” The test design consists of five 2-min stages,
totaling exactly 10 minutes, at incremental intensities using Borg’s Rating of Perceived
Exertion (RPE6-20) scale (Borg, 1982). Each 2-min stage is associated with an RPE value
and its verbal cue; stage one is clamped at an RPE of 11 (“fairly light”), stage two at 13
(“somewhat hard”), three at 15 (“hard”), four at 17 (“very hard”), and five at 20
(“maximal”). Although the results of their study received considerable criticism
surrounding research design issues, their results showed that untrained individuals were
able to attain a greater VO2max during a self-paced compared to traditional ramp GXT. In
reference to Noakes’ criticisms (2008), the self-paced testing delivered exercise in a
“closed loop” fashion that simulated the demands of a more ‘natural’ form of exercise as
evidenced by the final kick near the end of the test. Mauger and Sculthorpe (2012)
attributed this finding to the self-modulation of power output and subsequent feedback to
regulate fatigue, presenting a willingness to endure greater levels of discomfort with an
approaching test termination point. Other studies either confirm (Mauger et al, 2013;
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Astorino et al., 2015) or question (Chidnok et al., 2013; Hogg et al., 2015; Faulkner et al.,
2015) the utility of the self-paced GXT model to elicit a higher VO2max. However, the
underlying mechanism(s) that explain any differences between protocols have yet to be
fully elucidated. It has been reported that left ventricular (LV) volumes and twist
mechanics limit performance during incremental exercise (Stohr et al., 2011).
Furthermore, these limiting characteristics within the LV have a close relationship with
cardiac output (Q) and stroke volume (SV) (Stohr et al., 2011). Most recently, Astorino et
al. (2015) examined Q responses during self-paced and ramp GXT cycle protocols and
found that the greater VO2max during self-paced compared to ramp exercise was attributed
to a greater Q. Currently, there remains a need to examine the components that limit Q
(SV, filling volumes, contractility) during self-paced compared to traditionally applied
GXT. Furthermore, additional examinations should seek to further describe the
appropriateness of these protocols to elicit VO2max and the underlying metabolic
mechanisms (BLa-, ventilatory threshold attainment) that relate to its attainment.
Therefore, the aim of the current study is to compare the underlying hemodynamic and
metabolic responses during self-paced and ramp treadmill GXT protocols.
Problem Statement
Previous research has briefly examined the utility of self-paced GXT protocols in
eliciting VO2max, yet there remains a need to further elucidate the underlying mechanisms
that may support the utility of these protocols. Specifically, it has been shown that higher
Q contributes to higher VO2max; however, the limiting factors of Q (e.g., SV, diastolic
filling, contractility) that explains the difference in Q between protocols is currently
unknown. Furthermore, the self-modulation of power output may reflect differences in
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metabolic thresholds (BLa- and ventilation) that underscore performance during GXT
protocols.
Purpose of the Study
The purpose of the current study was to determine the suitability of self-paced
exercise and compare the hemodynamic (Q and SV) and metabolic (BLa- and ventilatory
threshold) responses between a self-paced and ramp treadmill GXT protocol.
Limitations
The following limitations were identified in this study:
1. The study sample consisted of healthy, active men aged of 18-45 years with ‘FairGood’ cardiorespiratory fitness. Therefore, the results of this study may not apply
to females, individuals who are sedentary, have chronic disease, and are outside
of the range for age and cardiorespiratory fitness.
2. All trials in the current study were performed on a treadmill. Therefore, the results
of this study are not as applicable to other modes of exercise.
Assumptions
The following assumptions were identified in this study:
1. Prior to each visit, the participant did not perform any vigorous exercise for 24
hours, did not ingest caffeine or alcohol for 12 hours, consumed the same small
meal 2-3 hours prior, and consumed enough water to maintain adequate
hydration.
2. Each participant was familiar with the use of the RPE scale as a metric to selfregulate exercise intensity.
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3. Each participant completed all GXT trials with maximal effort until volitional
exhaustion.
Hypotheses
The following hypotheses were tested in this study:
Hypothesis 1: When examining VO2max values on an individual basis, the self-paced
protocol will elicit higher values compared to the ramp GXT protocol.
A self-paced exercise testing protocols has been shown to demonstrate higher
VO2max values using both treadmill and cycle ergometer (Mauger and Sculthorpe, 2012;
Mauger et al., 2013; Astorino et al., 2015).
Hypothesis 2: The self-paced protocol will elicit a significantly (p < 0.05) higher Q
compared to the ramp GXT protocol.
Self-paced exercise resulted in a higher maximal Q when compared to ramp
exercise (Astorino et al., 2015)
Hypothesis 3: The self-paced exercise will not elicit a significantly (p < 0.05) higher
maximal heart rate (HRmax) compared to the ramp GXT protocol.
Although self-paced exercise has resulted in a higher HRmax when compared to
ramp exercise (Astorino et al., 2015; Hogg et al., 2015), most of the current literature
suggests no difference in HRmax between self-paced and ramp exercise (Mauger and
Sculthorpe; 2012; Mauger et al., 2013; Chidnock et al., 2013; Straub et al, 2014;
Faulkner et al., 2015).
Hypothesis 4a: Stroke volume (SV) will reach a plateau during self-paced and ramp
GXT.
To date, there has been no research on SV kinetics in response to self-paced GXT.
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Hypothesis 4b: Stroke volume (SV) will reach a plateau at a higher submaximal intensity
during self-paced compared to ramp GXT.
Stroke volume has been shown to frequently demonstrate a plateau during
submaximal exercise in active individuals; however, a potential mechanism to explain the
effectiveness of self-pacing could be the preservation of SV during maximal incremental
exercise (Strickland et al., 2006; Stringer et al., 2005; Dufour et al., 2004; Zhou et al.,
2001).
Hypothesis 5: The self-paced and ramp GXT will not differ in maximal BLaconcentration.
It has been suggested that lower levels of BLa- during exercise contribute to the
lower levels of metabolic perturbations during self-paced exercise (Astorino et al., 2015);
however, studies have shown no difference in maximal BLa- concentration between
protocols (Mauger et al., 2013; Chidnock et al., 2013; Faulkner et al., 2015; Straub et
al., 2014).
Hypothesis 6: The self-paced and ramp GXT will not differ in the intensity (%VO2max)
at which ventilatory thresholds are attained.
Although the self-selection of speed on the treadmill may lead to the ventilatory
thresholds being reached at a later point during the test (DaSilva et al., 2011), there is
currently no evidence to suggest that these thresholds will differ in the intensity at which
they are reached.
Hypothesis 7: The self-paced and ramp GXT protocols will not differ in maximal
arteriovenous oxygen difference (a-vO2).
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A previous study by Faulkner et al. (2015) suggests that the mechanism
highlighting differences between self-paced and ramp exercise may be differences in avO2; however, limited research has demonstrated no difference between the two protocol
types (Astorino et al., 2015).
Scope of the Study
Sixteen healthy active males between the ages of 18 and 45 years with ‘FairGood’ cardiorespiratory fitness (40-79th percentile) completed three different GXTs to
compare the hemodynamic (Q and SV) and metabolic (BLa- and ventilatory threshold)
responses between self-paced and ramp treadmill GXT protocols. To examine the
influence of a learning effect, two of the trials were self-paced while the other was a
speed-based traditional GXT. To fulfill these requirements, the initial trial was self-paced
and the final two trials were completed in a randomized order. After the conclusion of
each test, a supramaximal verification trial was performed to confirm the attainment of
VO2max within the accepted range of measurement error (3%). All hemodynamic
measurements were collected continuously during exercise using impedance
cardiography (ICG). Gas analysis was collected continuously using a metabolic cart, and
BLa- was analyzed before, immediately post-exercise, and 5-min post-exercise using a
portable lactate analyzer.
Significance of the Study
This study compared the differences in hemodynamic and metabolic responses
between a self-paced and speed-based traditional GXT protocol. Currently, there is a
need to further investigate the suitability of self-paced exercise protocols to elicit VO2max.
In circumstances where a set duration is required to complete a test, any results
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suggesting no differences between protocols indicates the potential use for self-paced
protocols in clinical, research, or performance settings. Furthermore, recent evidence
suggests a superior ability of self-paced exercise to elicit a greater Q response compared
to ramp exercise; however, it remains unclear as to which components of Q contribute to
such difference during speed-based treadmill GXT protocols. The results of this study
will contribute to the growing understanding of the overall utility of self-paced GXT
protocols and the physiological mechanisms that underpin any differences between selfpaced and speed-based traditional GXT protocols

Definitions
Afterload: The threshold pressure which the left ventricle must reach before blood can be
ejected from the left ventricle.
Arteriovenous oxygen difference (a-vO2): The difference in oxygen saturation between
arterial and venous blood representing oxygen extraction at the level of the tissue.
Blood lactate (Bla-): A metabolic byproduct of glycolysis, indicative of exercise intensity.
Carbon dioxide production (VCO2): The rate of carbon dioxide production as a result of
metabolism.
Cardiac output (Q): The amount of blood ejected from the left ventricle per minute.
End-diastolic volume (EDV): The volume of blood in the left ventricle at the end of
diastole.
Frank-Starling mechanism: The intrinsic mechanism within the myocardium by which an
increase in stretch (from increased blood volume and pressure) results in an increase in
left ventricular performance during systole.
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Graded exercise test (GXT): An exercise test designed to increase in difficulty as they
progress for examining maximal physiological responses and exercise tolerance.
Impedance cardiography (ICG): Noninvasive technology to measure the changes in
electrical impedance across the thorax to assess hemodynamic variables.
Oxygen uptake (VO2): The rate of oxygen consumption and utilization.
Preload: The amount of elastic tension stored within the cardiac myocytes because of
increasing blood volume and pressure in the left ventricle.
Pulmonary ventilation (VE): The amount of air moved in and out of the lungs per minute.
Rating of perceived exertion (RPE): An affective measurement to indicate individual
level of perceived exertion.
Respiratory exchange ratio (RER): The ratio of carbon dioxide production to oxygen
consumption (VCO2/VO2), indicative of exercise intensity and substrate utilization.
Stroke volume (SV): The amount of blood ejected from the left ventricle per beat.
VO2 plateau: A leveling or reduction in the rate of oxygen consumption despite the
increase in work rate.
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determination of VO2max: Historical perspectives, progress, and future considerations”
which has been published in the Journal of Sports Medicine. It is authored by Nicholas
Beltz, Ann Gibson, Jeffrey Janot, Len Kravitz, Christine Mermier, and Lance Dalleck.
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ABSTRACT
Graded exercise testing (GXT) is the most widely used assessment to examine the
dynamic relationship between exercise and integrated physiological systems. The
information from GXT can be applied across the spectrum of sport performance,
occupational safety screening, research, and clinical diagnostics. The suitability of GXT
to determine a valid maximal oxygen consumption (VO2max) has been under
investigation for decades. Although a set of recommended criteria exists to verify
attainment of VO2max, the methods that originally established these criteria have been
scrutinized. Many studies do not apply identical criteria or fail to consider individual
variability in physiological responses. As an alternative to using traditional criteria,
recent research efforts have been directed toward using a supramaximal verification
protocol performed after a GXT to confirm attainment of VO2max. Furthermore, the
emergence of self-paced protocols has provided a simple, yet reliable approach to
designing and administering GXT. In order to develop a standardized GXT protocol,
additional research should further examine the utility of self-paced protocols used in
conjunction with verification protocols to elicit and confirm attainment of VO2max.
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1. Brief History of Graded Exercise Testing
The examination of the dynamic human physiological responses during
incremental exercise has been an ever-evolving task for nearly 200 years. Beginning as
early as the 18th century and continuing through the 19th century, pioneering
physiologists such as Antoine Lavoisier and Nathan Zuntz have been credited with the
first scientific examinations involving exercising humans under normal and hypoxic
conditions. In 1918, Lambert described the use of a series of exercise tests to examine the
impact on blood pressure to establish a reliable index of myocardial efficiency [1].
Inspired by Lambert and the foundational works of Francis Benedict, Goran Liljestrand,
and August Krogh, British physiologist Archibald Vivian (A. V.) Hill conducted a
fundamental series of experiments that remain the genesis of exercise physiology as an
academic discipline [2]. Using Douglas bags to collect expired air samples, Haldane gas
analyzers to determine fractional concentrations of oxygen and carbon dioxide, and a
Tissot gasometer to measure air volumes, Hill and colleagues [3–6] repeated running
trials of increasing speeds to plot the relationship between intensity and oxygen uptake
(VO2). Interestingly, it was concluded that a “ceiling” or upper limit in the maximal
uptake of oxygen (VO2max) existed [7]. It must be appreciated that a difference exists
between VO2peak and VO2max and that these terms are often used interchangeably in the
literature. That is, VO2peak is the highest value attained during exercise and represents an
individual’s exercise tolerance while VO2max represents the highest physiologically
attainable value [8]. Interestingly, a VO2max is always a peak but a VO2peak is not
always maximal. The difference between VO2peak and VO2max is often determined by
the presence of a VO2 “plateau,” although the plateau depends on many protocol

18

variables. This review will further expound on this point. Hill’s experiments and a
century of observations before him led to the discovery of graded exercise testing (GXT),
the gold standard for quantifying cardiorespiratory fitness (CRF) and measuring
VO2 during incremental to maximal exercise.
2. Applications of GXT
Graded exercise testing is used to observe the dynamic relationship between
exercise workload and the integrated cardiovascular, pulmonary, musculoskeletal, and
neuropsychological systems [9]. Protocols require a systematic and linear increase in
exercise intensity over time until the individual is unable to maintain or tolerate the
workload. Selected cardiovascular, pulmonary, and metabolic variables are collected
during the test to evaluate exercise tolerance and represent the efficiency in which the
cardiovascular system is able to deliver oxygenated blood to working skeletal muscle and
the ability of muscle to utilize oxygen. Due to the widespread use of GXT in healthy
populations, normative criteria have been established to help practitioners identify
metabolic and ventilatory patterns. Moreover, these metabolic and ventilatory patterns
may even assist in categorizing cardiovascular disease (CVD) states and prognoses [9].
The assessment of exercise tolerance has been used to establish the relationship
between CRF, CVD, and all-cause mortality [10]. An early investigation by Blair et al.
[10] examined the relationship between fitness and mortality in 32,421 men and women
(20–80 years old) encompassing 264,978 living-years and 690 deaths. Their results were
in agreement with a previous investigation [11] that found substantial strength and
independence of low CRF as a predictor for all-cause mortality and future CVD.
Similarly, a meta-analysis by Kodama et al. [12] showed that a 1-MET
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(3.5 mL·kg−1·min−1) increase in VO2max was associated with a 13% and 15% reduction
in risk of all-cause mortality and CVD, respectively. Furthermore, a threshold to classify
a substantially higher risk for all-cause mortality and CVD was established as low CRF
(<7.9 METS) [12]. The evidence clearly demonstrates the influence of low CRF as an
independent precursor to mortality and underpins the application of standardized
protocols to monitor VO2max in specific populations. These studies highlight the
importance of accurate and reliable GXT results for minimal exercise tolerance and
clinical evaluation of health status [10–12]. Furthermore, valid GXT results are relevant
when interpreting studies using repeated measurements of VO2max (and not VO2peak) to
establish a training effect or design exercise prescription.
Accurately capturing the dynamic physiological responses during GXT is
essential to establish a valid VO2max and to quantify CRF responses throughout various
training interventions. Many independent factors contribute to the varying opinions
surrounding the appropriateness of current standardized GXT guidelines, thereby limiting
the ability to compare results between tests and population or apply them. The modes for
administering GXT are traditionally limited to cycle and treadmill, each resulting in
unique physiological responses. Protocol design variables such as stage length, workload
increment per stage, and total test duration may individually limit the accuracy of GXT.
Furthermore, the criteria used to confirm attainment of VO2plateau are not consistent or
universally applied among studies. This review will examine the limitations within the
current recommendations for GXT and highlight the importance of the continuous search
for identifying an optimal protocol.
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3. Applications of the Fick Equation
The importance of seminal works by Hill et al. [4–6] is apparent considering that
the fundamental basis for quantifying oxygen transport, utilization, and mitochondrial
energy production remain the same today as they did nearly 100 years ago. The Fick
equation states that VO2 is equal to the product of cardiac output (Q) and the difference
between arterial and venous oxygen content at the level of the capillary (a-vO2diff).
VO2 (mL•kg-1•min-1) = Q (L•min-1) x (a-vO2diff) (mL•L-1)
The equation can be expanded to represent as the product of heart rate (HR) and
left ventricular (LV) stroke volume (SV), with SV being parsed into the difference
between LV end-diastolic volume (EDV) and end-systolic volume (ESV).
VO2 (mL•kg-1•min-1) =
HR (beats•min-1)(EDV (mL•beat-1) – ESV (mL•beat-1)) x (a-vO2diff) (mL•L-1)
Altogether, the components of Fick represent individual central (Q) and
peripheral (a-vO2diff) factors. The central component consists of factors that impact the
diffusion of O2 from the external environment into the arterial blood supply and transport
of oxygenated blood to working skeletal muscle tissue. The peripheral component
comprises various cellular and molecular mechanisms at the skeletal muscle level to
diffuse O2from arterial blood to the mitochondria for consumption in the process of ATP
regeneration [13].
3.1. Implications of the VO2max Protocol

It has been well established that increases at a linear rate similar to VO2 upon the
initiation of incremental to maximal exercise [14–18]. In response to metabolically
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induced peripheral vasodilation in working skeletal muscle, blood pressure is maintained
by increases in HR and SV [16]. Central medullary control of baroreceptors,
chemoreceptors, and vascular tone contributes to the withdrawal of parasympathetic
activity coupled with an increase in sympathetic drive. The result is an overall increase in
chronotropic and inotropic characteristics of the heart.
Generally, HR increases linearly during incremental to maximal exercise;
however, a breaking point (i.e., HR threshold) is eventually obtained after which the
slope may increase or decrease until maximal heart rate (HRmax). The HR threshold is
an individual phenomenon that may indicate chronotropic insufficiency [19]. Moreover,
the significance of the flattened HR response following HR threshold, in particular, may
be associated with a downregulation in beta-1 adrenergic receptor activation during
greater exercise intensities. For instance, a study by Knight-Maloney et al. [19] examined
HR responses during incremental to maximal exercise in 14 healthy individuals and
found that eight subjects demonstrated a decelerated post-HR threshold response while
six subjects showed an accelerated post-HR threshold response. These findings are in
agreement with previous research that demonstrated the intersubject variability in HR
responses [20–24].
Alongside the increasing inotropic response, shifts in sympathetic nervous system
dominance raise chronotropic activity and influence central mechanical changes during
incremental to maximal exercise. Neural drive enhances myocardial contractility,
reducing ESV. Additionally, the intramuscular oscillations during exercise promote an
increase in venous return to the heart. The improved blood flow to the LV enhances
preload and promotes LV myocardial stretch, increasing elastic potential energy for

22

additional contractile force. This is known as the Frank-Starling mechanism [25]. The net
effect is an increase in SV, contributing to an increase during incremental to maximal
exercise. Contrary to traditional thought, SV within a healthy population may exhibit
individual linear or plateau responses that are dependent on many factors.
Pioneering work by Astrand et al. [26] evaluating the SV response to incremental
to maximal exercise established the widely accepted observation that SV plateaus are at
approximately 40–50% of VO2max [27, 28]. This finding was primarily attributed to
tachycardiac limitations on diastolic filling time, therefore reducing EDV and blunting
SV response [29]. More recently, a review by Vella and Robergs [30] underscores that
the potential determinants of the intersubject variability in SV are more complex than
originally established. Factors such as age, fitness level, and sex contribute to four main
SV responses: the classic plateau, plateau with subsequent drop, plateau with subsequent
rise, and gradual increase. While some studies have reported linear SV responses during
incremental to maximal exercise in older individuals [31, 32] other studies showed that
SV exhibited either a plateau or a subsequent drop at nonspecific points during
incremental to maximal exercise [18, 33–35]. Although it may be logical to suggest that
age has a negative impact on the maintenance of SV near maximal exercise due to
reductions in myocardial compliance, the overall relationship between age and SV
response remains unclear. Similarly, individual fitness level does not reliably predict the
trend in SV during exercise. Some investigations showed a constant increase in SV up to
maximal [36–39] and near maximal intensities [40] in trained individuals while others
reported a plateau in both trained and untrained subjects [32, 41] and progressive
increases until maximal exercise in untrained subjects [42–44]. One could postulate that

23

adaptations consequent to aerobic training enhance SV through combinations of the
following: increased blood volume leading to greater EDV, increased LV chamber size,
improved LV compliance, greater myocardial contractility, and reduced afterload may
explain the individual ability to increase SV progressively through incremental to
maximal exercise [30].
3.2. A-vO2diff Implications of the VO2max Protocol
It has also been accepted that an increase in was the sole component of
maintaining VO2 during the onset of exercise due to a potential lag between oxygen
demand and venous return [45–47]. This was tested by Casaburi et al. [48], who found
that pulmonary artery desaturation occurred as soon as four seconds after the onset of
150-Watt cycle exercise. The results reported by the Casaburi et al. [48] were questioned
by De Cort et al. [45] and attributed to immobilized vena caval blood. Compared to
Casaburi et al. [48], who measured a- upon exercise from rest, De Cort et al. [45] began
measurements starting at the first increase in VO2 after the abrupt increase in cycling
intensity from a submaximal level. Although a-vO2diff may improve with aerobic
training [49, 50], the cellular mechanisms contributing to oxygen extraction within
skeletal muscle also increase at a predictable rate during incremental to maximal
exercise. Recent meta-analyses by Montero et al. [51] and Montero and Diaz-Canestro
[52] examined the effects of aerobic training on a-vO2diff in untrained or moderately
trained healthy young (<40 years old), middle-aged, and/or older (≥40 years old)
individuals. These studies concluded that the improvements in VO2max from 5 to 52
weeks of endurance training were due to linear improvements in but not a-vO2diff.
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Therefore, the peripheral mechanisms are viewed as a complement to the central
mechanisms contributing to VO2max.
4. VO2max Protocol Critical Considerations
The foundational study by Taylor et al. [53] demonstrated that the sensitivity and
reliability of physiological responses during GXT were limited by subject characteristics
and GXT protocol design. In an attempt to investigate this issue, 115 healthy males (18–
35 years) completed a wide range of GXT protocols under various conditions of physical
stressors (caloric restriction, bed rest, temperature, and illness). It was the first
comprehensive study to examine the sensitivity and reliability of VO2max based on
modality, fitness status, illness, environment, gas sampling rate, test duration, and
speed/grade increments.
Since then, there has been a search for an optimal standardized protocol suitable
for the entire spectrum of fitness abilities and testing goals. The two modalities
commonly used in GXT are treadmill and cycle ergometry. While the treadmill appears
to be the most widely used modality due to familiarity with upright locomotion and
greater muscle mass utilization, cycling protocols present an opportunity to test
individuals with coordination or orthopedic limitations. Furthermore, opting to use a
cycle ergometer over treadmill may result in a more quantifiable workload (Watts) and
provides an opportunity to use a progressive ramp protocol allowing for more
reproducible outcomes [9]. However, VO2max attained using treadmill protocols tend to
produce up to 20% greater VO2max values when compared to cycle protocols [54, 55].
This difference is attributed to a larger recruitment of exercising skeletal muscle mass,
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and a-vO2diff, vascular conductance, and a lower rate of carbohydrate oxidation leading
to a less severe development of metabolic acidosis at submaximal intensities [15, 56–60].
Realizing the need to investigate physiological responses to the earliest standardized
GXT protocols, Pollock et al. [61] compared cardiopulmonary responses between four
widely used treadmill testing protocols in 51 men (22 active, 29 sedentary): Balke [62],
Bruce [63], Ellestad [64], and modified Astrand [65]. Each test differed in the method of
increasing work rate in a step fashion (either speed or grade). The Balke protocol
maintains a constant speed (3.3 mph) but increases grade by 1% each minute. The Bruce
protocol increases speed and grade every 3 min. The Ellestad protocol increases speed
each stage until the 10th minute upon introduction of a single increase in grade (to 5%)
followed by subsequent increases in speed. Finally, the Astrand protocol maintains a
constant running speed with increase in grade (2.5%) every 2 min. Pollock et al. [61]
observed a similar VO2max achieved between Balke, Bruce, Ellestad, and Astrand
protocols (39.4, 40.0, 40.7, and 41.8 mL·kg−1·min−1, resp.) despite the difference in
VO2 plateau attainment (69%, 69%, 59%, and 80% of participants, resp.). Interestingly,
this shows that the individual characteristics of similar protocols do not impact VO2max
but show inconsistencies in plateau. Their finding was one of the first to demonstrate the
impact of protocol design characteristics on the attainment of VO2max and a
VO2 plateau.
Early investigations by Whipp et al. [47] and Davis et al. [66] popularized the use
of ramp protocols on electronically braked cycle ergometers. It was proposed that ramp
cycle protocols would improve an individual’s ability to reach VO2max because the ramp
increased work in a much more continuous fashion when compared to step increases in
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work rate used in traditional treadmill protocols [67]. Since workload was deliverable in a
linear fashion, attention turned to examining the slope of the VO2-work rate
(ΔVO2/ΔWR) relationship. Buchfuhrer et al. [67] compared cycle tests of various
changes in work rates (15 W·min−1, 30 W·min−1, and 60 W·min−1) and noted that
ramping at an intermediate rate (30 W·min−1) produced the greatest VO2max values;
however, the work rate was dependent on fitness status. In a similar study, Zhang et al.
[68] compared multiple work rates (15 W·min−1, 20 W·min−1, and 30 W·min−1) applied in
continuous ramp versus step (1 min, 2 min, and 3 min) fashion. Interestingly, no
differences were found in aerobic parameters (VO2max, anaerobic threshold (AT),
AT/VO2max, and ΔVO2/ΔWR) between any of the protocols. Furthermore, this study
emphasized the importance of work rate increments independent of the stage length used.
In contrast, Myers et al. [54] showed that ramp protocols (treadmill and cycle)
represented a higher correlation between VO2 and workload compared to step, thus
reducing the error in predicting the metabolic cost at individual workloads. Muscat et al.
[55] completed the most comprehensive investigation to date, comparing physiological
responses (cardiometabolic function, gas exchange, breathing patterns, pulmonary
function, and leg discomfort) between ramp treadmill and ramp cycle protocol matched
for work increase (25 W/2 min) in 15 healthy young men. It was concluded that VO2,
VCO2, respiratory exchange ratio (RER), HR, O2 pulse, ventilation, and respiratory
muscle effort (diaphragm) responses were greater at maximal and submaximal workloads
for treadmill compared to cycle exercise; however, the responses in ventilatory
equivalents and ventilatory thresholds were similar. Their results suggested that either

27

mode may be applied for purposes of evaluating mode-specific fitness and determining
optimal training prescriptions when work rate increases are applied in a ramp fashion.
Similar to protocol mode (cycle versus treadmill), stage length, and work rate
increments (ramp versus step), GXT protocol duration should be considered when
comparing results. Buchfuhrer et al. [67] utilized 1-minute stage protocols to examine the
impact of protocol duration on the achievement of VO2max. Since VO2max values were
greater in protocols lasting between 8 and 17 min compared to tests outside these limits,
the current duration recommendation of 8–12 min was established [67]. More recently,
Yoon et al. [69] suggested that the Buchfuhrer et al. [67] study lacked appropriate
statistical power and commented that overall test duration (5–14 min) may depend on age
and training status [70–72]. Yoon et al. [69] compared VO2max and incidence of
VO2 plateau across four protocols of different durations (5, 8, 12, and 16 min) using a
cycle ramp protocol in moderate-to-highly trained individuals. They found that VO2max
was higher in men for the 8-minute protocol compared to 5-, 12-, and 16-minute
protocols, while there was no difference in VO2max in women. Further statistical analysis
attributed this sex difference to lower fitness levels and perhaps more importantly the
lower muscle mass (~45 kg in women versus ~67 kg in men) in women participating in
the study. The impact of fitness level on test duration suggests that the steeper
ΔVO2/ΔWR slope in shorter protocols may be disadvantageous to individuals of lower
fitness. This could be due to increased reliance on nonmitochondrial energy systems, thus
causing premature fatigue, as well as eliciting central cardiovascular limitations.
5. VO2max Protocol Paradigm Shift
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For the past 60 years the push to standardize GXT procedures has been essential
to progress understanding of the complex and sensitive interaction between exercise and
the integrated human physiological responses. In spite of the advancements that have
given test administrators the ability to control fixed increments of intensities in an openloop fashion (constant administrator testing variable manipulation without a fixed
termination time), recent research has introduced an alternative approach to exercise
protocols that allow the subject to self-pace the protocol in an incremental format [73–
75]. In effect, this type of protocol would not negate past research that emphasized the
role of the heart, lungs, circulatory, and other integrated systems in a limiting capacity
but rather challenge the role of the brain as a potential simultaneous regulator. Although
not entirely self-paced, studies by Pollock et al. [61, 76] used a model where speed was
adjusted to accommodate individual movement efficiency and workload was increased by
adding treadmill grade. In an effort to appreciate the evolution of self-paced protocols,
the Pollock et al. [61, 76] investigations underscore the importance of identifying
movement speeds that engage the greatest amount of muscle mass. Hagerman [77] was
the first to report the ability of an individual to reach a greater VO2 by self-pacing during
a simulated competitive time trial compared to laboratory-based testing methods. The
finding suggested that an individual’s ability to self-regulate muscular power output may
serve as the ultimate variable in maximizing physiologic responses. Intrigued by this
finding, Foster et al. [78] compared the physiological responses between a self-paced
laboratory 5-km cycle time trial and a GXT using a cycle ergometer. They found that
maximal VO2, HR, ventilation, and blood lactate (BLa−) levels were significantly greater
in the 5-km time trial compared to the cycle ergometer GXT. These initial findings raised
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an important fundamental question regarding exercise testing protocols: if an individual
possesses the ability to achieve a greater physiological ceiling when self-paced, does the
search for achieving standardized protocol procedures serve a pragmatic purpose?
Eston and Thompson [73] used a closed-loop (no constant administrator
manipulation and a fixed termination time) perceptually-regulated protocol guided by the
6–20 Rating of Perceived Exertion Scale (RPE) [79] to estimate maximal work rate in
patients receiving β-blocker treatment. Using 4 × 3 min stages at an RPE of 9 (“very
light”), 13 (“somewhat hard”), 15 (“hard”), and 17 (“very hard”), they reported that RPE
could be used to predict maximal functional capacity. Similar RPE protocols using
various stage lengths (2, 3, and 4 min) have been validated to accurately predict VO2max
[74, 80–83]. Using a similar perceptually regulated paradigm, Mauger and Sculthorpe
[75] investigated a self-paced cycle exercise protocol in 16 untrained university students.
The test design consisted of 5 × 2-min stages, totaling 10 min, at incremental intensities
utilizing Borg’s Rating of Perceived Exertion (RPE6-20) Scale [79]. The protocol was
designed as follows: stage one was clamped at an RPE of 11 (“fairly light”), stage two
clamped at an RPE of 13 (“somewhat hard”), stage three clamped at an RPE of 15
(“hard”), stage four clamped at an RPE of 17 (“very hard”), and the final stage clamped
at an RPE of 20 (“maximal exertion”). The unique aspect of the protocol was the
additional stage of “maximal exertion” (RPE 20) to the established series of 2 min RPEclamped stages as applied previously [80] in order to directly measure VO2max. The
participants achieved a significantly greater VO2max (40 ± 10 versus 37 ±
8 mL·kg−1·min−1) and peak power output (273 ± 58 versus 238 ± 55 Watts) in the selfpaced protocol compared to a traditional GXT despite the absence of significant
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differences in HRmax, RERmax, VEmax, and mean power output. It is important to note
that the results of Mauger and Sculthorpe [75] have received considerable criticism over
methodology. Their results have been attributed to discrepancies in test duration between
self-paced (10 ± 0 min) and traditional (13 ± 3 min) protocols and that direct GXT
protocol comparison must require a match in total test duration [84, 85]. Interestingly, the
closed-loop nature of the test elicited a motivation or “final push” during the final stage
of the test similar to that expected toward the end of an athletic competition. Moreover,
the results support the role of the brain during a closed-loop setting when the individual is
able to vary work rate constantly, balancing discomfort with a maintainable power output
and willingness to complete the test. The simplicity of the protocol design has produced
many speculative explanations for the results. Mauger et al. [86] showed that a speedbased self-paced treadmill test elicited significantly greater VO2max and HRmax values
compared to those relative to a traditional test. This study also received criticisms over
flawed methods and lack of control, attributing findings to using different modes
(motorized versus nonmotorized treadmill) and neglect of measurement error to test their
hypothesis [83, 87–89]. Follow-up studies have shown a higher VO2max attainment
during self-pacing using a cycle ramp protocol [90], similar VO2max attainment using
motorized treadmill [83, 91–93] and cycle protocols [84, 94], and a lower VO2max
attainment using an automated treadmill [89]. It is important to note that findings
showing no difference between self-paced and traditional protocols demonstrate the
potential utility for self-paced GXT protocols, particularly when considering protocol
duration. While test duration is tightly controlled during self-paced testing and the
incremental steps in oxygen cost between stages have been shown to fall within
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recommended guidelines (1-2 METS) [95], physiological measurements that may
distinguish self-paced from traditional protocols have yet to be adequately examined. It is
purported that underlying variables that comprise the Fick equation, namely, and avO2diff, and the role of blood flow redistribution may underpin differences between selfpaced and traditional protocols [92, 93]. More recently, Astorino et al. [90] showed that a
self-paced cycle protocol elicited higher VO2 compared to a ramp protocol (50.2 ±
9.6 versus 47.2 ± 10.1 mL·kg−1·min−1). Additionally, they were the first to compare
central cardiovascular responses between protocols and showed a higher Qmax during selfpaced compared to ramp (21.9 ± 3.7 versus 20.7 ± 3.4 L·min−1). It should be noted that
their average test duration was not tightly controlled to 10 min (9.6 ± 0.8 min); therefore
pacing was not restricted throughout the final 2-minute stage. Although initial results are
intriguing, the investigation into the efficacy and suitability of self-paced protocols is in
its infancy. Therefore, future researchers could choose to design studies to expound on
the intertrial reliability using self-pacing protocols. Additionally, studies should examine
the interaction between central, peripheral, and central regulating responses during selfpaced exercise.
6. VO2max Attainment Criteria
In order to increase the reliability and validity of a test, an undefined combination
of standardized criteria must be met during the GXT including the following:
VO2 plateau, estimated HRmax, RER, BLa−, and RPE. This widely accepted set of
characteristics, or VO2max criteria, has become a controversial topic of debate in recent
years due to the high intersubject variability in attaining the criteria [96–99].
Furthermore, the number and type of criteria used to determine VO2max are often
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contingent on the preference of the researcher or clinician administering the test [96].
Along with protocol design, other factors such as metabolic data processing methods and
participant effort make comparing the results for clinical or research purposes difficult
[53, 99, 100].
7. Detection of a VO2 Plateau
As with many of the principles used today in exercise physiology, the original
reports of a slowing or “plateau” of oxygen consumption despite increasing muscular
work can be attributed to Bassett Jr. and Howley [101]. Taylor et al. [53] later confirmed
the existence of a VO2 plateau in 9 of 13 men during a treadmill test of incremental speed
(increasing 1 mph) and 108 of 115 (94%) men during treadmill tests of incremental grade
(2.5%). Studies have since demonstrated that a VO2 plateau can be detected in 17% to
100% of subjects tested, suggesting that its existence represents an inconsistent
“phenomenon” [100]. Taylor et al. [53] were the first to apply the VO2 plateau criterion
of ≤150 mL·min−1, defined by a change in VO2 ≤150 mL·min−1 despite a continuous
increase in workload. This value, alongside the wide range of other values used as plateau
criteria (≤50 mL·min−1, ≤100 mL·min−1, ≤200 mL·min−1, and ≤280 mL·min−1), should
not be applied universally since the criteria must reflect the expected rate of VO2 increase
per unit time relative to the protocol design [102]. Among the most important factors
impacting the incidence of a VO2 plateau are age [103], testing modality [104], and data
analyses methodology [99, 105]. Astorino et al. [103] showed that the strongest predictor
of VO2 plateau among 30 men and women consisting of groups of endurance-trained
(n=9), recreationally active (n=11), and strength trained (n=10) individuals was age, not
training status, body composition, or training history. Gordon et al. [104] demonstrated
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that treadmill testing (58%) was superior to cycle ergometer testing (8%) at eliciting a
plateau. The diminished plateau in cycling was attributed to the increased metabolic cost
of the eccentric skeletal muscle activity in treadmill running compared to the
concentrically dominant cycle exercise. Furthermore, Astorino [105] confirmed that gas
sampling rate impacted the incidence of a plateau. In this study, 13 sedentary, 48
recreationally active, and 47 competitive athletes completed a GXT using treadmill and
cycle protocols. The group found that the incidence of plateau was greater using breathby-breath (81%), 15-sec (91%), and 30-sec (89%) averaging compared to a longer
sampling rate of 60-sec (59%). Collectively, these findings suggest that sampling rate in
conjunction with the plateau threshold criteria may explain much of the discrepancy in
incidence of VO2 plateau across studies.
7.1. Heart Rate Response to the VO2max Protocol
Due to its noninvasive nature, simplicity, and fairly predictable response to
incremental to maximal exercise, HR is often used as a secondary criterion to
VO2 plateau. Much like plateau and other secondary criteria, the criteria for HR are
highly variable. Typically, the threshold is established at a specific percentage using an
age-predicted HRmax equation. Surprisingly, Fox et al. [106] created the 220-age
equation by drawing an arbitrary best fit line from the observation of 10 studies [106].
Robergs and Landwehr [107] evaluated the Fox equation [106] and highlighted the fact
that there were no statistical methods used to establish the regression equation from their
data set. Instead, Fox and colleagues [106] summarize their methods by stating that “no
single line will adequately represent the data on the apparent decline of HRmax with age.
The formula, 220-age, defines a line not far from many data points.” Curious to
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investigate the mystery of 220-age, Robergs and Landwehr [107] replicated the data set
presented by Fox et al. [106], applied linear regression analysis, and found the equation
to be 215.4–0.9147 (age) with a ±21 bpm error. Tanaka et al. [108] cross-validated an
age-predicted HRmax equation by combining 351 studies (18,712 subjects) and a
laboratory investigation using 514 subjects (18–81 years old). Their regression analysis
established a new equation (208 − 0.7 × age) with a less, yet still substantial (±7–
11 bpm), error range. It was concluded that the 220-age equation underestimates agepredicted HRmax in individuals over the age of 40 years. For these reasons, equations
with less inherent error should be applied when using “±10 bpm of age-predicted
HRmax” as a secondary VO2max criterion.
7.2. RER Implication of the VO2max Protocol
The RER is another secondary VO2max criterion that is used to reflect the balance
between bicarbonate buffering and hydrogen ion accumulation in the face of incremental
exercise. Upon increasing metabolic acidosis, bicarbonate buffering leads to an increase
in CO2 production, increased ventilation, and a subsequent increase in RER. A series of
studies by Issekutz et al. [109, 110] was the first to examine the relationship between
RER and incremental exercise, VO2max, and the metabolic state of the exercising human.
Using a series of 4-5 min intermittent maximal exercise tests, they calculated the
difference between CO2 and the product of a metabolic respiratory quotient constant and
VO2 (CO2 − VO2 × 0.75). This value was termed “excess CO2” and used to reflect the
change in substrate utilization and exercise intensity with the increase in VO2 [109, 110].
Ultimately, they established the most widely used threshold for RER criteria (≥1.15)
today. Much like HR and VO2plateau criteria, a standard RER threshold value is not
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consistently applied, using 1.0, 1.05, 1.08, 1.10, 1.12, 1.13, or 1.20 to verify VO2max
attainment [96, 97]. The high intersubject variability in RER responses due to
inconsistent effort levels and training status makes higher RER values difficult to achieve
for many individuals [97].
7.3. VO2max and Blood Lactate Accumulation
Analysis of postexercise BLa− compared to preexercise BLa− has been used as a
reliable marker to quantify exercise intensity. Hill et al. [4–6] were the first to establish a
relationship between BLa− and exercise intensity during vigorous to maximal exercise.
Regardless of the debate for practical application or metabolic circumstances, it is agreed
that BLa− accumulation is related to an individual’s ability to tolerate and sustain
exercise; therefore, it is commonly used as a surrogate measure of the metabolic
perturbations during maximal exercise and a secondary VO2max criterion [111, 112]. The
origins of the criterion date back to an investigation by Astrand [113] who used
postexercise BLa− concentrations to verify VO2max in young (14–18 years) boys and
girls. Despite the fact that only half of the subjects demonstrated a VO2 plateau, it was
noted that the individuals who exhibited a plateau had postexercise BLa− concentrations
between 7.9 and 8.4 mM (average ≥ 8 mM). It has since been determined that factors
such as age, training status, sex, and overall effort may impact the level of BLa−. This has
led to the use of a ≥10 mM threshold or even a complete disregard for maximal
BLa−concentration due to the high intersubject variability (anywhere from 1.2 to 18 mM)
in postexercise lactate [96, 98, 114].
7.4. RPE Assessment in a VO2max Protocol
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The simplest and most controversial measurement traditionally used as a VO2max
criterion was developed by Borg [79], known as Borg’s Rating of Perceived Exertion
(RPE). While RPE is not a direct measurement of physiological responses, the
behavioral, motivational, and physical factors that an individual perceives during GXT
contribute greatly to the overall validity of the test. Many studies have shown a strong
relationship between RPE, HR, and VO2 [82, 115–117]; however, others have
demonstrated RPE to be less related to these variables in less active or sedentary
individuals [118, 119]. Interestingly, Noakes [120] suggested that thresholds may not be
as simple as limitations in central and peripheral components but rather controlled by a
“central governor” that regulates self-pacing and overall effort throughout various points
of a maximal exercise bout. Despite the relationship among RPE, HR, and BLa−,
inconsistencies in recent studies call to question the validity of RPE. Edvardsen et al.
[114] examined the attainment of the commonly used RPE criterion of ≥17 in 840
individuals (20–85 years) and found that 84% of the subjects were able to achieve the
criterion. Due to the variability and subjective nature of the criterion, Magnan et al. [121]
examined the attainment of an RPE ≥18 in 240 inactive individuals (18–45 years) and
found that 93.7% of the individuals reached the desired RPE threshold despite the fact
that only 59% were demonstrating a VO2 plateau. Overall, the assumptions in employing
an RPE criterion depend on the subject’s understanding of the scale and associated verbal
descriptors, ability to differentiate between discomfort and physiological fatigue, and
motivation.
8. Verification Protocols of VO2max
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Many of the current criteria used to determine VO2max were established with
technology that is no longer used today. Douglas bags and Tissot gasometers have been
replaced by sophisticated metabolic analyzing systems and pneumotach and turbine flow
measurement devices. Furthermore, the VO2max criteria were developed using certain
modalities (treadmill versus cycle) on relatively small samples of homogenous
populations. These reasons and the overall variability of the criteria have resulted in some
researchers rejecting secondary criteria altogether. Recent attempts have been made to
establish new VO2max attainment criteria through the introduction of a verification
protocol [97, 122–126]. The origin of the verification protocol is believed to exist in a
text by Thoden et al. [127], in which the first recommendation was made to include a
bout of supramaximal exhaustive exercise (higher workload than achieved during GXT)
following the completion of GXT. Since the inception of the verification protocol, there
has been much effort to establish verification protocol intensity, duration, rest period after
completing initial GXT, and the criteria used to verify VO2max attainment. In follow-up
guidelines, Thoden [128] recommended that the recovery phase between GXT and
verification protocol should be between 5 and 15 minutes and a workload of one stage
higher than the final completed stage during GXT should be used. Unfortunately, the
recommendations by Thoden et al. [127, 128] were theoretical rather than research-based
guidelines. The first study to directly examine the efficacy of a verification protocol was
done by NiemelÄ et al. [129], who performed a verification protocol at a workload equal
to the greatest workload achieved during initial GXT within a week of completing initial
GXT. Using a ±5% repeatability range for VO2max [130], they were able to confirm
attainment in 8 of the 16 subjects. Day et al. [8] sought to observe the differences
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between cycle GXT and a subsequent verification test in 38 healthy individuals (19–61
years) and reported no difference in VO2max using a workload of ~90% Wpeak. Followup studies commonly used verification workloads between 95 and 130% of peak
workload achieved during initial cycle GXT or 0.5 1.6 km·hr−1 higher than the peak
velocity achieved during initial treadmill GXT. The recovery time between tests ranged
from the same day [122, 126, 131–134], 1–10 min active rest [122, 132, 133, 135], and
5–60 min passive rest [125, 135], to separate day testing [8, 123, 126]. Furthermore, tests
were done on endurance-trained runners [122, 123], male athletes [135], recreationally
active men and women [122, 125, 126], sedentary men and women [105], and middleaged men and women [131]. Studies commonly revealed a nonsignificant mean
difference in VO2max between GXT and verification protocols when analyzed on an
individual, rather than group mean, basis within the ±5% measurement error (accuracy of
metabolic system when properly calibrated according to manufacturer) associated with
VO2 measurement [136–138]. Most recently, a study by Nolan et al. [125] investigated
the impact of two verification intensities and rest periods. After an initial treadmill test,
12 active males and females completed each of the following four verification conditions:
105% maximal GXT workload, 20 min rest; 105% maximal GXT workload, 60 min rest;
115% maximal GXT workload, 20 min rest; and 115% maximal GXT workload, 60 min
rest. Their results demonstrated a 100% success rate in verifying attainment of VO2max
when using 105% maximal GXT workload, regardless of the rest period between tests,
and highlighted the current recommendation for intensity and rest period optimization
during verification tests [125].
9. Error in VO2max Measurement
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The sophisticated metabolic systems used to collect and analyze data during
exercise testing represent the most sensitive and reliable means for laboratory-based
research. In order to compare results between studies, the data must be validated. Even if
metabolic systems are appropriately maintained and calibrated, measurement error of
±5% is commonly accepted [136–138]. A study by Yule et al. [139] reported a 15%
difference in VO2max between three identical systems in the same laboratory.
Furthermore, differences attributed to measurement error between 10 and 22% have been
reported when comparing identical testing protocols using different metabolic systems
[137]. A meta-analysis by Vickers [140] examined the test-retest reliability in maximal
exercise testing and found that the average standard measurement error was
2.58 mL·kg−1·min−1. To account for total error, however, a source of biovariation
reflecting the inherent biological fluctuations within an individual must also be
considered [141]. Knowing that the underlying assumption for comparing VO2max
between and within studies is that biological variability must account for a portion of
total error, Katch et al. [141] designed a study in which five participants completed an
average of 16 maximal exercise tests over the course of a 2–4-week period. They found
that, within the total error of ±5.6%, biological variability accounted for ~93% of the
error while measurement error accounted for only ~7%. Meanwhile, recommendations by
Balady et al. [138] report that the biological component of variability intrinsic to GXT is
commonly accepted within 3-4%. Due to the numerous factors that contribute to
biological variability and subsequent total error, an argument can be made against studies
that consider only manufacturers’ guidelines of measurement error when comparing tests
[142]. This can be represented by a scenario comparing VO2 responses to various
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protocol designs, whereas an individual who falls within the accepted measurement error
range between tests may have only done so based on the small contribution in variance
from the system rather than the large contribution from biological variability due to
heredity, homeostatic stress, training status, psychological stress, sleep, or nutrition [143].
For this reason, comparing attainment of VO2max between protocols may be more
reliable when considering total error (biological variability + measurement) rather than
measurement error alone.
10. Conclusion
Due to the valuable information gathered and the wide spectrum of applications
for the use of GXT, it has become an increasingly important objective to derive an
optimal set of standardized procedures for the determination of VO2max. Many years of
observations examining the potential sources for individual variability in GXT responses
are cited in the literature. Despite the pitfalls in physiological variability, standardized
tests using traditional methods for VO2max verification remain the most commonly
employed. Furthermore, the methods in which these criteria have been previously
established, as well as the comparison between studies evaluating the appropriateness of
universal protocols, do not consider combined sources of inherent measurement and
biological error. These reasons underpin the current suitability of more standardized GXT
guidelines and subsequent methods for determining test validity. More recent approaches
have highlighted alternative methods for measuring exercise capacity using a closedloop, self-paced testing model. Future research directions should seek investigating
perceptually regulated (RPE-clamped) protocols with verification protocols for the
overall suitability and individualization of GXT.
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CHAPTER 3
This chapter presents a research manuscript, entitled “Hemodynamic and Metabolic
Responses during Self-Paced and Ramp Graded Exercise Testing Protocols”. This
manuscript is authored by Nicholas Beltz, Fabiano Amorim, Nathan Cole, Ann Gibson,
Jeffrey Janot, Len Kravitz, Christine Mermier, Terence Moriarty, Tony Nunez, Sam
Trigg, and Lance Dalleck. The manuscript follows the formatting and style guidelines of
the journal Medicine & Science in Sports & Exercise. References are provided at the end
of the chapter. Figures are provided after the references.
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Abstract
PURPOSE: Compare metabolic and hemodynamic responses between self-paced (SP)
and ramp (RAMP) graded exercise testing (GXT) protocols. Given that SP is controlled
for time while RAMP is not, similarities in physiological responses between protocols
may support SP as a viable testing option from a time-management standpoint.
METHODS: Sixteen recreationally trained men (23.7±3.0 yrs) completed two separate
treadmill GXT protocols. SP consisted of five 2-min stages (10 min total) of increasing
speed based on the Borg RPE6-20 scale. RAMP increased speed by 0.16 km/hr every 15 s
until volitional exhaustion. All testing was performed at 3% incline. Oxygen
consumption (VO2) was measured via indirect calorimetry; hemodynamic function was
measured via thoracic impedance, and blood lactate (BLa-) was measured via portable
lactate analyzer. Differences between SP and RAMP protocols were analyzed as group
means by using paired samples t-tests SPSS v. (R Core Team (2017)). RESULTS:
Maximal values for SP and RAMP were similar (p>0.05) for VO2 (47.1±3.4 vs. 47.4±3.4
mL•kg-1•min-1), heart rate (198±5 vs. 200±6 beats•min-1), ventilation (158.8±20.7 vs.
159.3±19.0 L•min-1), cardiac output (26.9±5.5 vs. 27.9±4.2 L•min-1), stroke volume
(145.9±29.2 vs. 149.8±25.3 mL•beat-1), and arteriovenous oxygen difference (18.5±3.1
vs. 19.7±3.1 mL•dL-1), and peak BLa- (11.7±2.3 vs. 11.5±2.4 mM•L-1), respectively.
CONCLUSION: SP elicits similar physiological responses in comparison to RAMP.
These results support SP as a feasible GXT protocol. Electing to employ SP may benefit
clinicians and researchers from a time-management perspective.
Key Words: RPE-clamped, cardiac output, stroke volume, VO2max
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INTRODUCTION
Since its inception within the pioneering work of Hill, Long, and Lupton (14), the
concept of maximal oxygen consumption (VO2max) has been the most widely examined
variable in the field of exercise physiology (26). Typically, VO2max is obtained by
administering a graded exercise test (GXT) to examine the dynamic relationship between
exercise workload and the integrated cardiovascular, pulmonary, musculoskeletal, and
neurophysiological systems (1). Altogether, the relationship depicts the upper limits of
systems to collectively deliver oxygenated blood to working skeletal muscle and the
ability of skeletal muscle to utilize oxygen for work. Therefore, results obtained from a
GXT are the basis for a large spectrum of applications, ranging from clinical exercise
tolerance and appropriateness for surgery to research on the efficacy of aerobic training
programs in athletic performance.
Historically, GXTs were administered in a discontinuous fashion (34). That is,
responses to exercise were evaluated by completing a series of single-stage exercise tests
of incremental intensities on separate days. Taylor et al. (34) were the first to demonstrate
the reliability of such testing, noting that modality, fitness status, test duration, and
intensity increment were all important considerations when attempting to accurately
assess VO2max. In an effort to highlight inconsistencies between continuous GXT
protocols, Pollock et al. (28) evaluated the ability of four popular treadmill protocols
(Balke, Bruce, Ellestad, and Modified Astrand) to assess maximal cardiorespiratory
responses. Although no differences were found between tests for VO2max, the unique stepwise challenge applied by each protocol demonstrated the variability in ventilatory and
metabolic responses across protocols. Investigations by Whipp et al. (37) and Davis et al.
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(10) popularized the use of ramp protocols on electronically braked cycle ergometers.
Given the workload was delivered in a linear rather than step fashion, observations
examined the slope in VO2-workload relationships and the optimal progression of work
rates (6, 39). Since then, there has been a trend in research toward establishing an optimal
and standardized GXT protocol suitable for all fitness levels and testing goals.
Despite the widespread importance of measuring VO2max, the methodology in
which graded exercise tests are applied and even the conceptualization of VO2max itself
has created recent controversy (7, 19-21). Hagerman (12) originally reported confounding
evidence, highlighting the limitations of the continuous GXT by demonstrating the ability
of individuals to reach a greater VO2max during simulated competition compared to
laboratory-based methods. These findings suggested that an individual and their ability to
self-modulate muscular power output on a momentary basis may serve as the primary
variable in maximizing physiological responses during exercise. Therefore, strategies in
self-pacing similar to those exhibited during athletic competition may be the limiting
factor in performance during a GXT. Subsequently, Noakes (26) introduced a three-fold
model concerning the appropriateness and utility of continuous GXTs to elicit VO2max.
First, the test is administered in an “open loop” rather than “closed loop” fashion,
meaning that the participant is unaware of when the test will end. Second, the nature of
the exercise itself is not representative of natural exercise because it is delivered in
predetermined and fixed increments. Lastly, the subjectivity of the test may limit
reliability because the test only concludes upon the participant reaching volitional
exhaustion.
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These criticisms, coupled with the high inter-subject variability of the primary
(VO2 plateau) and secondary (rating of perceived exertion or ‘RPE’, blood lactate (BLa-),
respiratory exchange ratio, heart rate) criteria applied to verify the attainment of a “true”
VO2max have led to the recent application of self-paced GXT protocols coupled with
supramaximal verification bouts. Mauger and Sculthorpe (21) developed a novel “closed
loop” GXT design that does not rely on predetermined and fixed intensity increments by
a test administrator, but rather allows the participant to self-select intensity throughout
the bout via “RPE clamping”. Their test design consists of five 2-min stages, totaling
exactly 10 minutes at incremental intensities using Borg’s Rating of Perceived Exertion
(RPE6-20) scale (Borg, 1982). Each 2-min stage is associated with an RPE value and its
verbal cue, with stage one clamped at an RPE of 11 (“fairly light”), stage two at 13
(“somewhat hard”), three at 15 (“hard”), four at 17 (“very hard”), and five at 20
(“maximal”). Although the results of their study received widespread criticism
surrounding research design, their results showed that untrained individuals were able to
attain a greater VO2max during a self-paced (SP) compared to traditional ramp GXT. In
reference to Noakes’ criticisms (26), the SP testing delivered exercise in a “closed loop”
fashion that simulated the demands of a more natural form of exercise as evidenced by
the final kick near the end of the test. Mauger and Sculthorpe (21) attributed this finding
to the self-modulation of power output and subsequent feedback to regulate fatigue,
presenting a willingness to endure greater levels of discomfort with an approaching test
termination point. Other studies either confirm (2, 20) or question (7, 11, 13, 15, 31, 33)
the utility of the SP GXT model to elicit greater VO2max. However, the underlying
mechanism(s) that may explain any differences between protocols have yet to be fully
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elucidated. It has been reported that left ventricular (LV) volumes and twist mechanics
limit performance during incremental exercise (32). Furthermore, these limiting
characteristics within the LV have a close relationship with cardiac output (Q) and stroke
volume (SV) (32). Recently, Astorino et al. (2) examined Q responses during SP and
ramp GXT cycle protocols and found that the greater VO2max during SP compared to
ramp exercise was attributed to a greater Q. Currently, there remains a need to further
examine Q and characterize SV kinetics in SP compared to traditional ramp treadmill
GXT protocols. Furthermore, additional examinations should seek to describe the
appropriateness of these protocols to elicit VO2max and the underlying metabolic
mechanisms (BLa-, ventilatory threshold (VT) attainment) that relate to its attainment.
Therefore, the aim of the current study was to compare the underlying hemodynamic and
metabolic responses during SP and ramp treadmill GXT protocols.
METHODS
Sixteen males (age 23.6±3.0 years; height 175.2±5.7 cm; weight 81.5±11.0 kg;
and body fat 17.1±5.0%) participated in the current study. All subjects were active (30
min/d, 3 d/wk, for at least 3 consecutive mo), had “Fair” to “Good” cardiorespiratory
fitness based on age as categorized by the American College of Sports Medicine (22),
and were between the ages of 18 and 45 years. As confirmed by the health-history
questionnaire, all subjects were free of known cardiovascular, metabolic, respiratory, or
renal disease, orthopedic limitations, and any other condition that would preclude safe
maximal treadmill exercise. The study was approved by the University of New Mexico
Institutional Review Board and all subjects provided written informed consent prior to
participating in the study.
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Experimental Overview
The study design included three separate visits to the laboratory over a 2- to 3-wk
period. To avoid variation, all trials were performed under controlled environmental
conditions and using the same equipment. Furthermore, trials were performed at the same
time of day (± 2 hrs) and were separated by at least 48 hours but no more than seven
days. Participants were told to refrain from vigorous exercise 24 hours, alcohol and
caffeine 8 hours prior to all testing sessions. Volunteers were also instructed to consume
the same small meal 2-3 hrs prior to each trial, arrive adequately hydrated, and maintain
their current training routine throughout the duration of the study. During the first visit,
participants were familiarized with the protocol and the Borg Rating of Perceived
Exertion (RPE6-20) Scale (5). A 5-min familiarization warmup was performed with the
ramp (RAMP) protocol where each participant started at a walk and increased speed by
0.16 km/hr every 15 s. Participants then completed a SP graded exercise test on a
treadmill followed by a verification bout of exercise to confirm the attainment of VO2max.
The verification bout has been reported in previous studies as a suitable alternative
criterion compared to traditional secondary verification criteria to confirm attainment of
VO2max (2, 24, 27). Furthermore, the verification bout was employed following the
completion of each GXT bout during the study. Following the completion of the first
trial, screening was performed to determine further participation in the study as defined
by the inclusion criteria of “Fair” to “Good” cardiorespiratory fitness. Prior to the second
visit, the protocol order performed during the remaining two trials was randomized to
prevent a learning effect. For example, if the subject performed SP on the second trial,
they performed RAMP on the third trial and vice versa.
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Exercise Testing
Each session began with the barefoot measurement of height (HR-200, Tanita
Corporation of America, Inc., Arlington Heights, IL, USA), body weight (Model 884,
Seca, Hamburg, Germany), resting blood pressure (Diagnostix 703, ADC, Hauppauge,
NY, USA), and resting BLa- (Lactate Plus, Nova Biomedical, Waltham, WA).
Throughout the study, all blood lactate measurements were obtained in duplicate and
averaged. During the first session, body density was estimated using standardized
skinfold (Lange, Beta Technology, Ann Arbor, MI, USA) measurement procedures at the
chest, abdomen, and thigh and then converted to body fat (16).
Prior to the GXT, subjects performed a 5-min warm-up at a self-directed pace on
the motorized treadmill (c966, Precor, Woodinville, WA, USA). Upon completion of the
warm-up, subjects then completed either SP or RAMP in the order previously described.
Immediately following the initial GXT bout, the mouthpiece was removed and the
subject rested quietly for 10 min. Blood lactate was collected immediately post-exercise
and 5 min into the rest period. After the rest period, each subject completed a verification
trial to confirm attainment of VO2max. The verification trial began with the subject
exercising at 30% max speed attained during the GXT (Vmax) for 2 min, 40-45% Vmax for
1 min, and 105% Vmax until volitional exhaustion. The total time to exhaustion during the
105% Vmax stage is typically 90-180 s (2). The attainment of VO2max was confirmed if the
VO2max during the verification trial did not exceed the accepted measurement error (3%)
of the ParvoMedics True One 2400 metabolic system (Sandy, UT, USA) (24). VO2max
was determined in all tests to be the mean of the two highest 15-s values during any 30-s

63

period of the test. Work rates were calculated for all protocols using the appropriate
ACSM walking and running equations and converted to METs (22).
Self-Paced GXT
Prior to SP, each subject was familiarized with the RPE6-20 scale and to the selfpaced nature of the maximal exercise test. The SP was a 10-min test comprised of five 2min stages. Each stage corresponded to a value on the RPE6-20 scale and a verbal cue,
where stage one is clamped at an RPE of 11 (“fairly light”), stage two at 13 (“somewhat
hard”), three at 15 (“hard”), four at 17 (“very hard”), and five at 20 (“maximal”).
Participants were instructed to modify their running speed on a moment-by-moment basis
so that their effort reflected the desired RPE intensity and associated verbal cue. Running
speed was adjusted by pressing the up or down arrow on the motorized treadmill, and the
grade was kept at 3% throughout all exercise trials. Participants were blinded to the speed
during exercise.
Ramp GXT
To determine the starting RAMP speed, the VO2max attained during the
familiarization session was multiplied by a factor of 1.15 based on the ~15%
overestimation of the ACSM equation for the metabolic cost of treadmill running (18)
and served as the 10-min endpoint goal. The endpoint workload was reduced by 0.16
km/hr every 15 sec until reaching the zero timepoint. The workload during RAMP was
delivered in a continuous ramp fashion, where speed was increased by 0.16 km/hr every
15 sec until the subject reached volitional exhaustion. Identical to the SP, grade was
maintained at 3% throughout all exercise trials. RPE6-20 was collected during the final 15
seconds of each stage.
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Metabolic Gas Collection
During all exercise trials, metabolic gases were continuously measured using
breath-by-breath sampling to obtain all respiratory variables (VO2, expired carbon
dioxide (VCO2), pulmonary ventilation (VE)). The metabolic cart was calibrated before
each GXT trial in accordance with manufacturer guidelines.
Hemodynamic Variable Collection
Hemodynamic variables (Q, SV) were measured continuously throughout all
exercise trials using impedance cardiography (ICG) (PhysioFlow Enduro, Manatec,
Strasbourg, France). A detailed description of ICG and the underlying principles and
assumptions can be found in previous literature by Richard et al. (29). Prior to exercise,
six sites were prepared (two neck, sternum, ribcage, and two back) and electrodes were
placed in accordance with manufacturer guidelines and connected to the PhysioFlow
leads. Calibration was also performed before each exercise test with the subject in a
standing position as recommended by manufacturer guidelines. Similar to the methods
reported by Astorino et al. (2), all variables were averaged and recorded every 15 sec
during exercise. Arteriovenous oxygen difference (a-vO2diff) was determined by
calculating the quotient of (VO2/Q).
Data Processing
To obtain VT, all respiratory gas data (VO2, VCO2, VE) were processed using an
11-breath averaging technique (30). VT was established using bisegmental piecewise
linear regression where the breakpoint in the VE-VCO2 relationship (4) was the VCO2
value with the least mean square error. To identify breakpoints in SV, data were analyzed
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as 30-sec averaged values and then plotted against time. Breakpoints in the time-SV
relationship were established using identical methods to VT breakpoints.
Statistical Analysis
All data are presented as mean ± SD and 95%CIs. Data were initially evaluated at
the univariate level for conformance with the assumptions for t-test processing. A paired
samples t-test was used to examine the differences in gas exchange and hemodynamic
variables between protocols. A two-way (protocol x time point) repeated-measures
ANOVA was used to identify differences in BLa- across time points (pre, immediatepost, 5-min post) and differences in workload (METs) and oxygen consumption (VO2)
across stages between SP and RAMP protocols. A post hoc Bonferroni correction was
applied when a significant difference was observed. Day-to-day variability of VO2max was
calculated between the familiarization and SP tests by taking the mean of the percentage
change between trials, as absolute values, for each subject. A Bland-Altman 95% limitsof-agreement (LoA) was used to quantify the agreement (bias ± random error [1.96 x
SD]) between the SP and RAMP VO2max measurements. Linear regression analysis was
used to examine the VO2-time relationship for each protocol. Effect size was established
using Cohen d, where 0.2, 0.5, and 0.8 represent a small, medium, and large effect,
respectively (8) and η2 where appropriate. Alpha was set a priori at p < 0.05 throughout
all statistical analyses. Piecewise regression models were analyzed using the R Core
Team (2017) statistical package. All other analyses were performed using the SPSS
version 20 (IBM, Chicago, IL).
RESULTS
Table 1 highlights the individual rate of attainment for select criterion confirming
VO2max. Overall, criteria with the highest success rate for this sample were HRmax ± 10

66

bpm (32 of 32 total tests), RPE6-20 >19 (32 of 32), and verification VO2max no more than
3% higher than GXT (32 of 32). A notable discrepancy was observed in the attainment of
a VO2 plateau ≤150 mL•min-1 during the last minute of exercise between SP (11 of 16)
and RAMP (15 of 16). Verification VO2max ±3% from GXT had the lowest rate of
individual protocol (SP: 12 of 16); RAMP: 9 of 16) and total test total test (21 of 32)
attainment.
INSERT TABLE 1 HERE
Differences in gas exchange, work rate, and metabolic data between protocols
The mean difference ± SD for dependent variables during SP and RAMP is shown
in Table 2. Total test duration was not significantly different between SP (600 ± 0 s) and
RAMP (606 ± 59 s) protocols; p > 0.05, 95% CI (-38 – 25), d = .157. The maximal speed
(Vmax) attained during the test was significantly higher in SP (14.5 ± 1.9 km•hr-1)
compared to RAMP (13.6 ± 0.8 km•hr-1); p < 0.05, 95% CI (0.2 – 1.6), d = .634. The
individual VO2max differences between SP and RAMP for all 16 subjects is shown in
Figure 1. VO2max was mathematically higher in 11 of the 16 subjects during the RAMP
compared to the SP protocol and the corresponding 95% LoA were 0.375 ± 2.783
mL•kg•min-1 (Figure 2). There were no differences revealed for relative VO2max between
SP (47.1 ± 3.4 mL•kg•min-1) and RAMP (47.4 ± 3.4 mL•kg•min-1) protocols; p > 0.05,
95% CI (-1.13 – 0.38), d = .111. Group data for VO2-time relationship during SP and
RAMP protocols are shown in Figure 3 and the workload-time relationship for each
individual stage is highlighted in Figure 4. Linear regression showed strong linear VO2time relationships for SP (VO2 = 0.059 (time) + 15.52; r = 0.88; adjusted R2 = 0.78; p <
0.05) and RAMP (VO2 = 0.055 (time) + 18.9; r = 0.85; adjusted R2 = 0.73; p < 0.05).
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Analysis revealed a significant stage x protocol interaction between SP and RAMP for
workload (p < 0.05; η2 = .353) and VO2 (p < 0.05; η2 = .330). There was no significant
difference in VO2max between the familiarization session SP (46.3 ± 3.2 mL•kg•min-1)
and the second SP and the day-to-day variability was calculated at 2.6%. No significant
differences between SP (158.8 ± 20.7 L•min-1) and RAMP (159.3 ± 19.0 L•min-1) were
observed for VEmax; 95% CI (-3.23 – 2.25), d = .025. No significant difference was found
in VT attainment between SP (78.2 ± 7.2%) and RAMP (79.0 ± 7.6%), represented as a
percentage of VO2max; p > 0.05, 95% CI (-5.7 – 4.2), d = .104. Additionally, there was no
significant time x protocol interaction revealed between SP and RAMP for pre-test,
immediate post-test, and 5-min post-test BLa- (1.0 ± 0.3 vs. 1.0 ± 0.2 mM•L-1; 10.3 ± 2.0
vs. 11.2 ± 2.3 mM•L-1; and 11.2 ± 2.3 vs. 11.5 ± 2. mM•L-1, respectively; p > 0.05, d =
1.03).
INSERT TABLE 2 HERE
INSERT FIGURE 1 HERE
INSERT FIGURE 2 HERE
Differences in hemodynamic responses between protocols
Maximal HR was generally higher during RAMP (200 ± 6 bpm) compared to SP
(198 ± 5 bpm), although not statistically significant; p > 0.05, 95% CI (-5.7 – 4.2), d =
.104. There was no difference in Qmax between SP (26.9 ± 5.4 L•min-1) and RAMP (27.9
± 4.2 L•min-1); p > 0.05, 95% CI (-4.15 – 2.4), d = .219. Results also showed no
difference between SP and RAMP protocols for SVmax and a-vO2max (145.9 ± 29.2 vs.
149.8 ± 25.3 mL•beat-1 and 18.5 ± 3.1 vs. 19.7 ± 3.1 mL•dL-1, respectively; p > 0.05).
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Figure 5 shows the group SV-time relationship for SP and RAMP protocols as 30-sec
averaged values. The SV response during SP demonstrated a breakpoint at a time-point
corresponding to 78% VO2max, in which the rate of change prior to the breakpoint (0.106
mL•s-1) was 2.9-fold greater than the change thereafter (0.036 mL•s-1). The SV-time
relationship during RAMP showed a breakpoint at a time-point corresponding to 58%
VO2max, where the rate of change prior to the breakpoint (0.398 mL•s-1) was 19.3-fold
greater than the rate of change thereafter (0.020 mL•s-1).
DISCUSSION
The current study sought to examine the suitability of a time-limited, perceptuallyregulated GXT protocol by comparing differences in metabolic and hemodynamic
responses between SP and RAMP. To our knowledge, this is the first study to
characterize hemodynamic variables and SV kinetics associated with a SP on a treadmill.
Furthermore, this study was designed to examine two speed-driven protocols that have
been previously established as an effective means to elicit reliable VO2max responses in
high-fitness individuals (11, 15, 31); however, the suitability of a treadmill ramp protocol
had yet to be determined for a homogenous group of individuals having a moderate
fitness level.
The utility of SP in the current study was examined by comparing VO2max values to
those attained during RAMP; there was no significant difference between protocols.
Previous studies have produced conflicting results, where SP has been shown to elicit
higher (20), similar (11, 13, 15), or lower (31) VO2max values during treadmill exercise. In
an effort to reduce the need for manual control during SP, a recent study by Scheadler
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and Devor (31) employed an automated treadmill to assess VO2 responses during SP and
modified-Astrand protocols in trained runners. The automated treadmill adjusted speed
based on the location of the runner on the belt and corresponding distance from a sonar
range finder located behind the treadmill. They reported a significantly lower VO2max in
SP (63.4 ± 7.8 mL•kg•min-1) compared to the modified-Astrand (64.9 ± 8.2 mL•kg•min1

). Unlike Scheadler and Devor (31), our study design contained a SP protocol during the

initial familiarization session. The reason for the initial SP was two-fold: 1) to familiarize
the recreationally-active but moderately-fit men to the effort required in maximal testing,
and 2) to conceptualize the ‘pacing strategy’ during the test. Although the difference
between the familiarization SP and RAMP were not significantly different, they trended
toward a lower (P =.06) familiarization SP trial value. The highly-trained individuals in
the Scheadler and Devor (31) study should have been familiar with ‘pacing’ but the lack
of maximal SP during the familiarization session may have attributed to their findings.
Moreover, the ingenuity of implementing a radar system could have shortcomings in the
way of a processing lag between the sensing and feedback in the system, resulting in
unwarranted oscillations in running speed.
Despite no difference for VO2max in the current study, previous studies showing
higher VO2max in SP have not gone without criticism. Mauger and Sculthorpe (21) were
the first to establish a higher (8%) VO2max in cycle SP compared to traditional methods;
however, follow-up studies (7, 33) have have established opposing results and attribute
their findings to a difference in total test duration (10 ± 0 min in SP vs. 13 ± 3 min).
Previous literature suggests that total test duration may impact peak physiological
responses and, therefore, must be considered when directly comparing protocols (6, 38).
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The current study was designed to control for test duration, resulting in analogous total
test time between SP (10.0 ± 0 min) and RAMP (10.1 ± 1 min). Moreover, all 16
participants completed RAMP within the recommended duration of 8-12 minutes
suggesting that any differences between protocols were physiological rather than
methodological. Mauger et al. (20) completed the only study to show higher VO2max
utilizing a treadmill design, but have been criticized for their methods in comparing SP
on a nonmotorized treadmill and traditional GXT on a motorized treadmill. Protocol
design was a unique feature of this study knowing that individuals are given full
autonomy to change speed at any point throughout the SP test. During pilot testing,
individuals regularly adjusted speed in 15 s-1 min increments during SP. Therefore, our
design applied more frequent and smaller increments in work rate (0.16 km•h-1 every 15
s) during traditional GXT than protocols used in studies by Hanson et al. (13) (3-min
stages), Scheadler and Devor (31)(2-min stages), Faulkner et al. (11) (1 km•h-1 every 2
min), and Hogg et al. (15) (1 km•h-1 every 2min). Work rate delivered in a ramp fashion
allows for comparison to studies utilizing cycle ergometers.
INSERT FIGURES 3 and 4 HERE
The VO2 and work rate responses in Figures 2 and 3 are a visual representation of
the pacing strategy involved during SP exercise. As expected, both work rate (calculated
by speed) and the measured VO2 were lower (p < 0.05) in SP throughout each of the first
three stages of the test. The significantly higher change in work rate (p < 0.05) from
stages 2 to 3 is reflected in a lag in O2 kinetics and the higher change in VO2 from stages
3 to 4 until the hallmark characteristic of SP, the ‘kick’ or end-spurt that highlights their
likeness to a competitive scenario. Maximal velocity (Vmax) attained during SP was
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higher (p < 0.05) compared to RAMP (14.5 ± 1.9 vs. 13.6 ± 0.8 km•hr-1) despite no
differences in VO2max. This finding aligns with those reporting higher Vmax attainment
during SP compared to traditional treadmill protocols (15, 31). It has been hypothesized
that the lower work rates during SP mitigate the disturbance within the metabolic milieu
by modulating power output from select motor units and allowing an individual to access
more type II fibers during the final stage, thus demonstrating a final burst of exertion (2,
31). Although the current study did not measure motor unit activation, differences in
central motor command and motor unit dominance were related to key metabolic markers
(VT and BLa-). Accordingly, there is potential that a proposed ‘central governor’ model
may tightly modulate work rate during SP via peripheral tissue afferent feedback and
reflect a delayed onset of peripheral fatigue and such metabolic disturbances (muscle
metabolite accumulation, VT) resulting in a greater activation of anaerobic fibers during
the maximal stage (25). Our results do not support this hypothesis as no differences were
observed between SP and RAMP for VT or peak BLa- (see Table 2).
Explanations for varying physiological responses between protocols have often
been purported to involve underlying mechanisms within blood flow and oxygen
extraction. Astorino et al. (2) recently investigated the role of maximal oxygen transport
and extraction as a means to augment the VO2 response during cycle SP and RAMP
across individuals of different fitness status. Their findings suggest that the higher
VO2max in SP (50.2 ± 9.6 mL•kg•min-1) compared to RAMP (47.2 ± 10.2 mL•kg•min-1)
was enhanced by higher HR and Q responses during the SP exercise. The hemodynamic
results of the present study are not in alignment with those reported by Astorino et al. (2)
and may be explained by our initial finding of no difference in VO2max. Interestingly, the
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participants in the current study exhibit VO2max values similar to those in the moderate
fitness group in Astorino et al. (2); however, Q and a-vO2diff in the current study more
closely resemble those in the high fitness group in Astorino et al. (2). The difference in
testing modalities between study design may explain this contrast in the VO2, Q, and avO2 relationship where treadmill exercise places a greater demand on blood flow and
extraction than cycling. Original studies investigating SP trials suggest that differences in
VO2max may be explained by differences in peripheral oxygen extraction (15, 20).
Similarity of VO2max values found between protocols in this study is supported by no
difference in blood delivery and extraction. It is worthwhile to note that the similarities
in SVmax support the findings by Astorino et al. (2), but their study was not intended to
describe and characterize differences in SV kinetics throughout SP and RAMP.
Therefore, the SV responses described in this study may provide useful insight regarding
pacing and components of central blood flow regulation. It has been accepted that SV
exhibits a plateau ~40-50% VO2max in response to the decrease in diastolic filling time
throughout incremental exercise. A review by Vella and Robergs (35) suggests that SV
kinetics can be characterized as having one of four responses to incremental exercise: 1)
progressive increase; 2) plateau with secondary increase; 3) plateau, or 4) plateau with
drop. Fitness level is believed to have the greatest influence on SV response but mode,
age, and sex may all play important roles. Figure 5 depicts the SV response during SP
and RAMP. It appears that protocol design may influence SV behavior at submaximal
exercise intensities. Stroke volume remains lower in SP at submaximal intensities,
reflected in the lower work rates and VO2, but observation of the individual slopes show
a plateau occurring at a time-point relating to 58% and 78% VO2max in RAMP and SP,
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respectively. Furthermore, the overall SV response during RAMP may be characterized
as a plateau while SP exhibits a final ‘kick’ in SV (plateau with secondary increase),
evidenced by a greater change in work rate during the final stage in SP but not VO2max. In
this case, we would likely not observe a lag in VO2 kinetics and subsequently greater
VO2max values had the test continued for an additional stage. This can be reasoned with a
degree of confidence given that each individual completed a supramaximal test after SP
and none of the 16 subjects exhibited VO2max values greater than the measurement error
of the metabolic cart (3%). Therefore, pacing during SP may not be as modulated by
peripheral metabolic disturbances to the degree that is a conservation and regulation of
blood flow.
INSERT FIGURE 5 HERE
A discrepancy between achieving significant and practical difference should be
considered when evaluating VO2max as group means rather than on an individual basis.
The expected range of variation owed to measurement error of a metabolic system is
typically 3-4% (3) between tests. The 2.6% day-to-day variability in SP found in the
current study is similar to that reported by Scheadler and Devor (31) (2.3%) and Straub et
al. (33) (3%), but the concept of total error (measurement + biological variability) cannot
be ignored when comparing separate-day tests. Katch et al. (17) found that the expected
total error of separate day tests is ±5.6%, with 93% of the total error accounted for in
biological variability and 7% in measurement error. This means that although statistically
different, any two tests within 5.6% can be considered similar while tests outside of that
range are meaningfully different. Only one of 16 subjects in the current study was outside
the acceptable range of total error (5.7%), which supports the use of SP as a valid testing
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protocol.
This study is not without its limitations. First, even though the two SP tests were
not statistically different, there was a degree of novelty for the moderately-trained
individuals to complete a test in which they needed to pace themselves. Although they
were familiarized with the RPE6-20 scale, their strategies changed drastically between the
familiarization SP and second SP in that their approach during the second test represented
a much more gradual and ramp-like pace. For this reason, the reliability of underlying
data other than VO2max collected during SP may rely on at least one familiarization
session, and multiple familiarization sessions may be advantageous for lesser-trained
individuals. Second, the criteria to determine VO2max has yet to reach universal
application. The current study used the criteria recommended by Midgley et al. (24) and
was verified in all 32 tests used in analyses; however, two participants needed to repeat
trials due to unmet criteria. If more strict criteria were applied such as HRmax ≤ 4 bpm
(23) or verification and GXT VO2max ± 3% (9, 36) then our participants would not have
initially met criteria. Studies should aim to detail verification criteria and individual
success rates so that future studies may know which criteria apply to their specific study
population. Finally, although none of the participants reported treadmill speed as a
limiting factor during testing, performing the tests at slightly higher inclines may have
moderated this limitation and resulted in different VO2max responses.
CONCLUSION
This study is the first to compare hemodynamic responses during SP and RAMP
treadmill graded exercise testing protocols. Specifically, there were no differences in
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maximal Q, SV, or a-vO2diff between protocols. Moreover, there were no differences in
VO2max values between protocols when analyzed as group means as well as when
considering total error (biological + measurement) on an individual basis. The findings in
the current study showing no difference in VO2max attainment, maximal hemodynamic
response, or maximal BLa- may seem unfavorable; however, the authors view them as the
contrary. These results further support the application of SP as a valid treadmill GXT
protocol and demonstrated a difference in SV response between SP and RAMP. The
time-regulated and open-loop protocol design of SP may mitigate error associated with
unsatisfactory protocol duration. Future research should continue to evaluate the utility of
SP on various populations (age, sex, fitness status, disease state) and even examine the
responses during SP protocols of various stage length, test duration, and RPE
assignments.
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Figure 1. Comparison of mean absolute maximal oxygen uptake (VO2max) values for selfpaced (SP) and ramp (RAMP) in all 16 subjects. Individual data are represented by the
dotted line graph. Statistical analysis revealed no difference in VO2max between SP and
RAMP protocols (P < 0.05).

Difference between RAMP and SP
VO2max (mL•kg•min-1)
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Average VO2max (mL•kg•min-1)
Figure 2. Narrowest 95% limits of agreement (bias ± [1.96 x SDdiff], mL•kg•min-1)
between ramp and self-paced protocols.
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Figure 3. Group mean oxygen uptake (VO2) data for self-paced (SP) and ramp (RAMP)
throughout the 10-min test duration.
*-significant difference (P < 0.05) at time point between protocols.
#-significant difference (P < 0.05) in within-stage change between protocols.
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Figure 4. Group mean work rate (METs) data for self-paced (SP) and ramp (RAMP)
throughout the 10-min test duration.
*-significant difference (P < 0.05) at time point between protocols.
#-significant difference (P < 0.05) in within-stage change between protocols.
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Figure 5. Group stroke volume responses over time for ramp (RAMP) and self-paced
(SP) graded exercise testing protocols. Plateau was identified using bisegmental linear
regression. Plateau for RAMP occurred at ~90s and 58% VO2max, where the rate of
change prior to the breakpoint (0.398 mL•s-1) was 19.3-fold greater than the rate of
change thereafter (0.020 mL•s-1). Plateau for SP occurred at ~300s and 78% VO2max,
where the rate of change prior to the breakpoint (0.106 mL•s-1) was 2.9-fold greater than
the change thereafter (0.036 mL•s-1).
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Table 1. Results of individual VO2max attainment criteria for all tests.
Criterion
VO2plateau (≤150 mL•min-1)
HR (± 10 bpm)
RER (≥1.15)
BLa- (>8mmol)
RPE (>19)
Verification ±3% from GXT
Verification no more than 3%
higher than GXT

SP RAMP
11/16 15/16
16/16 16/16
13/16 14/16
15/16 15/16
16/16 16/16
12/16
9/16
16/16

16/16

Total (%)
81.3
100.0
84.4
93.8
100.0
65.6
100.0
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Table 2. Differences in gas exchange, hemodynamic, and metabolic parameters between
protocols (mean ± SD).
Variable
VO2max (mL•kg•min-1)
VO2max (L•min-1)
HRmax (bpm)
VEmax (L•min-1)
VT (%VO2max)
Qmax (L•min-1)

SP
47.1 ± 3.4
3.83 ± 0.5
198 ± 5
158.8 ± 20.7
78.2 ± 7.2
26.9 ± 5.4

RAMP
47.4 ± 3.4
3.85 ± 0.5
200 ± 6
159.3 ± 19.0
79.0 ± 7.6
27.9 ± 4.2

95%CI
(-1.13 - 0.38)
(-0.08 - 0.03)
(-3.4 - 0.1)
(-3.23 - 2.25)
(-5.7 - 4.2)
(-4.15 - 2.04)

p-value
.308
.398
.065
.71
.746
.479

SVmax (mL•beat-1)
a-vO2max (mL•dL-1)
Time (s)
Vmax (km•hr-1)

145.9 ± 29.2
18.5 ± 3.1
600 ± 0
14.5 ± 1.9*

149.8 ± 25.3
19.7 ± 3.1
606 ± 59
13.6 ± 0.8

(-19.9 - 12.3)
(-3.4 - 0.9)
(-38 - 25)
(0.2 - 1.6)

.62
.24
.664
.015

BLa- (mM•L-1)
0.081
Pre
1.0 ± 0.3
1.0 ± 0.2
(-0.1 – 0.2)
**
**
IPE
10.3 ± 2.0
11.2 ± 2.3
(-1.9 – 0.2)
***
5 min
11.2 ± 2.3
11.5 ± 2.4
(-0.6 – 1.0)
VO2max: maximal oxygen consumption; HRmax: maximal heart rate; VEmax: maximal
ventilation; VT: ventilatory threshold; Qmax: maximal cardiac output; SVmax: maximal
stroke volume; a-vO2max: maximal arteriovenous oxygen difference; Vmax: maximal
velocity; BLa-: blood lactate concentration; IPE: immediately post exercise
*-significant difference (P < 0.05) between SP and RAMP
**-significant (P < 0.05) change from baseline
***-significant difference (P < 0.05) from IPE

d
.111
.044
.297
.025
.104
.219
.140
.399
.157
.634
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CHAPTER 4
SUMMARY, CONCLUSIONS, AND RECOMMENDATIONS
Summary
This research team was the first to examine and compare the hemodynamic
responses to self-paced GXT protocols and ramp treadmill protocols performed on a
treadmill in a homogenous group of young, moderately-trained males. Specifically, we
investigated: 1) the overall utility of SP by comparing attainment of VO2max to that of
RAMP, 2) differences between central (Q and SV) and peripheral (arteriovenous oxygen
difference) hemodynamic variables between protocols, 3) stroke volume kinetics to
highlight potential central command mechanisms, and 4) variables associated with the
level of metabolic disturbances during these protocols. The published review manuscript
found in Chapter 2 entitled “Graded Exercise Testing Protocols for the Determination of
VO2max: Historical Perspectives, Progress, and Future Considerations” encompasses all
relevant peer-reviewed literature to date examining the responses during and the overall
utility of perceptually-regulated self-paced graded exercise testing protocols. This paper
demonstrates that, though SP may serve as a valid alternative to more traditional
protocols, the physiological responses during SP that underpin mixed results remain to be
fully elucidated.
The research manuscript entitled, “Hemodynamic and Metabolic Responses
during Self-Paced and Ramp Graded Exercise Testing Treadmill Protocols” found in
Chapter 3 provides evidence that SP may serve as an alternative to RAMP treadmill
testing protocols in college-aged, moderately-trained men. Furthermore, the SV response
exhibited during self-paced exercise may provide insight concerning in central command
as it relates to ‘pacing’ strategy during maximal graded exercise.
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Conclusions
Perceptually-regulated self-paced graded exercise tests are a reliable alternative to
a ramp graded exercise test protocol. Given the consideration for total test duration when
designing a graded exercise test, a self-paced protocol might be particularly beneficial
from a time-management standpoint. We conclude the following regarding our study of
hemodynamic and metabolic responses during self-paced and ramp graded exercise
testing treadmill protocols:
1. Self-paced and ramp protocols do not differ in maximal oxygen uptake.
2. Measures of maximal blood flow (cardiac output and stroke volume) and peripheral
oxygen extraction (arteriovenous oxygen difference) are similar between protocols;
however, the stroke volume patterns exhibited during protocols may highlight
characteristics relating to central command.
3. There are no differences in markers of metabolic disturbance (blood lactate
accumulation and ventilatory threshold) between protocols.
Recommendations
Several questions remain regarding the value of self-paced protocols. We did not
find any differences between self-paced and ramp protocols regarding hemodynamic or
metabolic responses; however, we suggest future research apply a design that examines
the utilities of these protocols in homogenous samples (age, sex, fitness level, disease
status). These studies should seek to preemptively control for differences in ergometers to
mitigate the chance of poor study design as an explanation for significance of findings.
Furthermore, it would be interesting to see more advanced statistical analyses to describe
potential differences in hemodynamic responses by examining individual rather than

88

group responses. Finally, there remains to be a study manipulating variables other than
speed within a self-paced protocol. Total time duration could be increased or decreased
or the rating of perceived exertion (RPE) 0-10 scale could be used in place of 6-20. It was
clear throughout the course of this study that familiarization with the RPE6-20 scale and
concept of ‘pacing’ was crucial for individuals lacking prior experience with them.
Practically speaking, it may benefit the time-efficient nature of self-paced protocols if
methods were tested to reduce the importance of familiarization sessions during selfpaced exercise.
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APPENDIX A.
Comparison of hemodynamic responses between self-paced and standard ramp
protocols.
Consent to Participate in Research
01/05/17
Purpose of the study: You are being asked to participate in a research study that is
being done by Dr. Len Kravitz, who is the Principal Investigator and his associates from
the Department of Health, Exercise, and Sports Sciences. This study will not be funded
by any organization. The purpose of this study is to compare the cardiovascular responses
between two different graded exercise tests with males. You are being asked to take part
in this study because you are a healthy individual between the ages of 18 and 45 years
old, who engages in > 30 minutes physical activity on at least 3 days per week. Up to 40
people will take part in this study at the University of New Mexico. All study visits will
take place in the Exercise Physiology Lab at the University of New Mexico.
This form will explain what to expect when joining the research, as well as the possible
risks and benefits of participation. If you have any questions, please ask one of the study
researchers.
What you will do in the study:
•
•
•
•
•

You will be asked to visit the Exercise Physiology Lab in Johnson Center at the
University of New Mexico, Albuquerque, NM on three separate occasions.
All visits will be separated by a minimum of 2 days and a maximum of 7 days
with all visits completed within a 3-week time frame.
Prior to each visit, you will be asked not to perform any exercise 24 hours before
the visit, not ingest caffeine or alcohol 24 hours prior to the visit, and to consume
at least a pint of water as well as a small meal 2-3 hours before the visit.
The first visit will take up to 90 minutes and the remaining two visits will take up
to 60 minutes.
During your first visit you will do each of the following:
o Complete physical activity/health history questionnaire. You will be asked
to fill out this questionnaire about your health and that of your close
relatives in order to screen for any issues that could cause additional risk
to you by being a part of the study.
o Your height and weight will be measured, and body fat will be estimated
via skinfold (SKF) measurements. The SKF measurements are done using
a skinfold caliper to measure a double layer of skin and underlying
(subcutaneous) fat. The sum of the SKF measurements is used to estimate
body density (Db). The determined Db is used to estimate percent body
fat.
o You will then be asked to perform a maximal oxygen uptake test (VO2
max) on either cycle ergometer or treadmill (based on personal preference)
for approximately 10 minutes. This test will require you to pedal on a
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•

stationary cycle ergometer or run on a treadmill with an increasing
intensity (controlled by the participant) until you cannot continue. You
will have a mouthpiece in your mouth (somewhat like a snorkeling
breathing device) and a nose clip on your nose. This equipment is
connected to a gas analyzer to measure your exhaled oxygen and carbon
dioxide throughout each trial.
o During exercise, an alcohol swab will be used to prep your skin and pairs
of electrodes will be placed at specific sites on your neck, chest (just
below the collarbone next to the sternum), trunk (just below the bottom of
the sternum), and back. This equipment uses electrical signals (noninvasive and similar to a 12-lead EKG) to measure the function of your
heart. For quality assurance, the electrodes may need to be secured using
tape. You will be asked about allergies to glue prior to applying tape.
o We will be measuring the level of lactate in your blood. To do this the
researcher will collect a drop of blood from your ear 3 times during each
visit. This will occur before you begin to exercise, immediately after you
finish exercising, and 5-minutes post exercise.
o In the self-paced protocol, you will gradually increase the intensity of the
cycle or treadmill throughout the test by manually changing the workload
in accordance to your rating of perceived exertion (how hard you feel you
are working) on a scale of 6-20. This rating scale will be explained to you
in detail. The entire test will consist of five 2-minute stages.
o Upon completing the graded exercise protocol, the mouthpiece will be
removed and you will recover for 20 minutes. After a light exercise (walk)
recovery period, you will begin to warm-up for 2-minutes. At this point,
the intensity will be set to a level 5% greater than the maximal intensity
achieved during the initial graded exercise test. You will be asked to
exercise at that level until you can no longer continue. This usually takes
between 1.5-3min. If this test does not confirm VO2 max, you may need to
return for additional testing.
o If this verification trial does not confirm VO2max, you have the option to
withdraw from the study and not return for additional trials or testing.
During your second visit and third visits the following will occur:
o At visit 2- The exercise test type (either self-paced or ramp) that you will
be asked to perform will be randomly chosen for you by a flip of a coin.
o At visit 3- You will perform the exercise test type that was not done at
visit 2. For example, if self-paced exercise was performed at visit 2 you
will do the ramp exercise testing or vice versa.
o Before the start of the warm-up, you will be re-familiarized with the
procedures of the graded exercise test.
o In the case of performing a ramp exercise protocol, you will complete a
different type of test on the same mode (cycle or treadmill) than you
performed on the first visit.
o In the case of performing a self-paced protocol, you will repeat the same
graded exercise protocol that you completed during the first visit. The selfpaced protocol is a 10-min exercise test and requires that you (the
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o

o
o
o
o

participant) will gradually increase the exercise intensity throughout the
test based your own perception of effort. The test will conclude once you
have reached a point where you cannot continue.
During the ramp protocol, you will complete a maximal oxygen uptake
test (VO2 max) for approximately 8-12 minutes. This test will require you
to pedal on a stationary cycle ergometer or run on a treadmill with an
increasing intensity until you cannot continue. This test is different in that
it will not be controlled by your rating of exertion (how hard you feel you
are working). Instead, the researcher will control the gradual increase in
exercise intensity until you reach a point where you cannot continue.
All other procedures will be the same as the first trial, other than the way
the intensity of the exercise increases.
Your rating of perceived exertion (how hard you feel you are working) on
a scale of 6-20 will be recorded at the end of each 2-min exercising stage
Blood lactate will be measured via a total of 3 pinpricks to the ear to
collect a sample of a drop of blood before you begin exercising,
immediately post-exercise, and 5-minutes post exercise.
At visit 2 you will be asked to schedule your final visit, which will take
place at least 2 days but no more than 7 days after the completion of visit
2.

Participation in this study will take a total of 3.5 hours over a period of three separate
visits. The first visit will last approximately 90-minutes while the second and third visits
will last approximately 60-min each.
Risks: Every effort will be made to protect the information you give us. However, there
is a risk of loss of privacy and/or confidentiality that may result in hardship or
inconvenience. There are risks associated with maximal/submaximal exercise testing
including the following: brief feelings of nausea, lightheadedness, muscle cramps, or
dizziness. According to the American College of Sports Medicine, the risk of a cardiac
event in normal healthy individuals during a maximal exercise test is minimal, 0.0006%
(6 in 10,000). The mouthpiece/headgear/nose clip can be uncomfortable, especially
during exercise. We will adjust the gear to be as comfortable as possible. There is a risk
of discomfort when we prick your ear to obtain a drop of blood for the measurement of
lactate, which will happen eight times per visit. There is a very small risk of infection
when blood is drawn, however, sterile techniques and trained personnel will be used to
limit this risk. There are no known risks associated with the placement of electrodes and
the measurement of heart function. There are risks of stress, emotional distress, injury,
and inconvenience associated with participating in this study.
Benefits: There will no direct benefits to you. However, it is hoped that information
gained from this study will help us understand the suitability of self-paced protocols for
the purpose of assessing VO2max. For your personal information, you will be given the
results of your maximal exercise tests, your VO2max, and body fat percentage within two
weeks of completing the study.
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Confidentiality of your information: Your name and other identifying information will
be maintained in locked files, available only to authorized member of the research team
for the duration of the study. For any information entered into a computer, the only
identifier will be a unique study identification (ID) number. If you decide to withdraw
from the study, all data which has been previously collected will be destroyed
immediately. Any personal identifying information and any record linking that
information to study ID numbers will be destroyed at the conclusion of the study.
Information resulting from this study will be used for research purposes and may be
published; however, you will not be identified by name in any publications.
We will take measures to protect the security of all your personal information, but we
cannot guarantee confidentiality of all study data. The University of New Mexico
Institutional Review Board (IRB) that oversees human subject research may be permitted
to access your records. Your name will not be used in any published reports about this
study.
Payment: Upon completing all trials for this study, you will be compensated with a gift
card equal to $60 for your time and inconvenience. Compensation will not be pro-rated
by trial. Therefore, you must successfully complete all trials to receive compensation.
Research related injury:
If you are injured or become sick as a result of this study, any emergency treatment will
be at your cost. No commitment is made by the UNM to provide free medical care or
money for injuries to participants in this study.
It is important for you to tell the Principal Investigator immediately if you have been
injured or become sick because of taking part in this study. If you have any questions
about these issues, or believe that you have been treated carelessly in the study, please
contact the Office of the IRB at (505) 277-2644 for more information.
Right to withdraw from the study: Your participation in this study is completely
voluntary. You have the right to choose not to participate or to withdraw your
participation at any point in this study without penalty. Any such data which may have
been previously collected will be destroyed if you do decide to withdraw from the study.
You will be given the results of all testing you completed before withdrawal.
If you have any questions, concerns, or complaints about the research study, please
contact:
Len Kravitz, Ph.D.
University of New Mexico Department Health, Exercise and Sport Sciences
Johnson Center, MSC04 2610
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1 University of New Mexico
Albuquerque New Mexico 87131
(505) 277-4136
lkravitz@unm.edu
If you would like to speak with someone other than the research team or have questions
regarding your rights as a research participant, please contact the IRB. The IRB is a
group of people from UNM and the community who provide independent oversight of
safety and ethical issues related to research involving people:
UNM Office of the IRB, (505) 277-2644, irbmaincampus@unm.edu. Website:
http://irb.unm.edu/
CONSENT
You are making a decision whether to participate in this study. Your signature below
indicates that you have read this form (or the form was read to you) and that all questions
have been answered to your satisfaction. By signing this consent form, you are not
waiving any of your legal rights as a research participant. A copy of this consent form
will be provided to you.
I agree to participate in this study.
_________________________
Name of Adult Participant

_________________________
Signature of Adult Participant

_______
Date

Researcher Signature (to be completed at time of informed consent)
I have explained the research to the participant and answered all of his/her questions. I
believe that he/she understands the information described in this consent form and freely
consents to participate.
_________________________
Name of Research Team Member

_________________________
_______
Signature of Research Team Member Date
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APPENDIX C.
HEALTH HISTORY QUESTIONNAIRE (RESEARCH ONLY 5/20/02)
Subject #_____________________________

Date___/___/___

Phone #: home________________________ cell_______________
Date of Birth ___/___/___Age____ Gender____ Ethnicity_______

Phone _________

Address
(home)_______________________________________________________zip________
email_____________________________________
Primary health care provider and health insurance________________________________
(Only for information/emergency contact)
Person to contact in case of emergency:
name_____________________________phone #_______________________________
¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨

MEDICAL HISTORY
Self-reported: Height______ Weight______
Physical injuries:__________________________________________________________
Limitations______________________________________________________________
Have you ever had any of the following cardiovascular problems? Please check all that
apply.
Heart attack/Myocardial Infarction____
Chest pain or pressure
____
Arrhythmias/Palpitations
____
Congestive heart failure
____

Heart surgery
Swollen ankles
Heart murmur

____
____
____

Valve problems
_____
Dizziness
_____
Shortness of breath _____

Have you ever had any of the following? Please check all that apply.
Hepatitis/HIV
Rheumatic fever
Kidney/liver disease
Diabetes (specify type)
Emphysema

_____
_____
_____
_____
_____

Depression
_____
High blood pressure_____
Obesity
_____
Asthma
_____
Stroke
_____

Cancer (specify type)
Thyroid problems
Total cholesterol >200 mg/dl
HDL cholesterol <35 mg/dl
LDL cholesterol >135 mg/dl
Trygylcerides>150 mg/dl

__________
_____
_____
_____
_____
_____
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Do immediate blood relatives (biological parents & siblings only) have any of the
conditions listed above? If yes, list the problem, and family member age at diagnosis.
________________________________________________________________________
Is your mother living? Y N
Is your father living? Y N

Age at death______ Cause___________________
Age at death______ Cause___________________

Do you currently have any condition not listed that may influence test results? Y

N

Details__________________________________________________________________
________________________________________________________________________
Indicate level of your overall health. Excellent ____ Good ____ Fair ____ Poor_____
Are you taking any medications, vitamins or dietary supplements now?

Y

N

If yes, what are
they?___________________________________________________________________
Do you have allergies to any medications? If yes, what are they?
________________________________
Are you allergic to latex?

Y

N

Have you been seen by a health care provider in the past year?

Y

N

If yes, elaborate
_______________________________________________________________________
Have you had a prior treadmill test? Y
were the results?

N.

If yes, when?______________ What

________________________________________________________________________
____________
Have you ever experienced any adverse effects during or after exercise (fainting,
vomiting, shock, palpitations, hyperventilation)? Y N If yes,
elaborate.________________________________________________________________
¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨

LIFESTYLE FACTORS
Do you now or have you ever used tobacco?
How long?______

Y

Quantity____/day

N

If yes: type ________________

Years since quitting______________

How often do you drink the following?
Caffeinated coffee, tea, or soda _______oz/day
_______oz/week

Hard liquor _______oz/wk

Wine

Beer _______oz/wk
Indicate your current level of emotional stress. High____

Moderate ____

Low____

¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨¨
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PHYSICAL ACTIVITY/EXERCISE
Physical Activity
Minutes/Day (Weekdays)

Minutes/Day (Weekends)

______/______ average

______/_____ average

Do you train in any activity (eg. jogging, cycling, swimming, weight-lifting)?
Y

N

How well trained are you? _________________________________________________
Vigorous Exercise (>30 Minute sessions)
_________Minutes/hours a week
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APPENDIX D.
My name is Nick Beltz and I am a researcher in the Health, Exercise, and Sports Sciences
Department at the University of New Mexico. I am emailing you to notify you of a
research study we are conducting in which you may be an eligible participant. The
research study is investigating the differences in hemodynamic responses between two
different graded exercise testing protocols. If you are a healthy male between the ages of
18 and 45 years who is physically active (> 30 minutes of activity at least three days per
week) you may be eligible to participate. Throughout the study you will have your body
fat %, oxygen consumption and hemodynamic measurements taken (via non-invasive
cardiac impedance). Additionally, a drop of blood will be collected at multiple time
points to measure blood lactate. This study will require 3 visits to the research laboratory
and require you to be at the laboratory a total of 3.5 hours. Please contact Nick Beltz at
nbeltz@unm.edu or Len Kravitz at lkravitz@unm.edu if you are interested in
participating and would like to learn more about the study.
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